GUIDELINES FOR

INSPECTION OF GMP COMPLIANCE

BY ASU DRUG INDUSTRY

Department of AYUSH,
(Drug Control Cell)
Ministry of Health and Family Welfare,
Government of India.

: Department of AYUSH, Ministry of Health & Family Welfare, Government of India,

New Delhi-2013
ISBN: 978-81-910195-8-2
Publisher: Department of AYUSH, Ministry of Health & Family Welfare, Government of India,
New Delhi, www.indianmedicine.nic.in
Disclaimer: This manual has been prepared on the basis of provisions in the Drugs and
Cosmetics Rules, 1945 for inspectors and ASU drug manufacturing units aimed at providing
orientation and training about various aspects related to Inspection of Ayurveda, Siddha and
Unani drug manufacturing units. The contributors and reviewers have taken due care to ensure
correctness of the contents before publication and cannot be held responsible for any omission
or inadvertent errors, nor can they warrant that all aspects of the subject have been covered.
The manual is a guiding tool and does not have any connotation of legal binding.
Users of this manual are welcome to provide their feedback and suggestions for any
improvement to Drug Control Cell, Department of AYUSH, B Block, GPO Complex, INA,
New Delhi-110023 by mail or by email at [email protected]

ii

ACKNOWLEDGEMENT
Department of AYUSH thankfully acknowledges the contribution of all those, who were involved
in preparation of the Inspection Manual.
Guidance and facilitation

Shri Nilanjan Sanyal, Secretary, Department of AYUSH

Shri Bala Prasad, Joint Secretary, Department of AYUSH

Content compilation

Dr. G. C. Gaur, Technical Officer (Ayurveda), Department of AYUSH

Dr. Hanumant Singh Kathait, Research Officer (Ayurveda), Department of AYUSH

Dr. Muzamil Rehman, Research Officer (Unani), Department of AYUSH

Dr. Mahendra Kumar Pal, Consultant (Homoeopathy)

Technical editing and review

Dr. D. C. Katoch, Joint Advisor (Ayurveda), Department of AYUSH

Appraisal, comments and editorial inputs

Dr. Rajeev Sharma, Director I/C Pharmacopoeial Laboratory for Indian Medicine.

Dr. Abdul Kabir Dar, Director, ISM&H, Govt. of J&K

Dr. Rampal Somani, Former Asstt. Drug Controller (Ay), Rajasthan

Dr. Rajeev Kumar Kurele, Manager QC/QA/F&D, IMPCL

Dr. Anand Chaudhary, Associate Professor (Rasashastra), IMS-BHU

Dr. Subhash C. Mandal, Senior Drug Inspector, Govt. of West Bengal

iii

CONTENTS AT A GLANCE

TOPIC

Page No.

Introduction

Chapter I: GMP: An Overview.

GMP

Importance of GMP

Basic Principles of GMP

Legal provisions for GMP

Roles and responsibilities of Inspectors conducting GMP inspection

Role of the Licensing Authority regarding GMP certification

10

Chapter II: Legal provisions for GMP certification

11

Rule as in Drugs & Cosmetics Rules 1945 regarding Manufacture for

Sale of Ayurvedic (including Siddha) or Unani Drugs

11

Schedule T

21

Format of various forms used by Inspectors and other

Regulatory Officials

42

Chapter III: Stepwise points for conducting GMP inspection

56

Chapter IV: Modalities for issuance of WHO GMP Site Certificate and
CoPP for Herbal Products

70

iv

INTRODUCTION
Drugs and Cosmetics Act 1940 and Rules thereunder provide for appointment of Inspectors of
Ayurveda, Siddha & Unani (ASU) systems of medicines who play significant role in implementation
of Drugs & Cosmetics (D&C) Act 1940 and Rules thereunder. One of the important tasks of
Inspectors working under the State Licensing Authority of ASU systems is inspection of ASU
Drug manufacturing Units before issuing license to manufacture ASU drugs under the provisions
of the D&C Act and Rules thereunder.
Training level and experience of Inspectors for the purpose of regulatory implementation varies
because qualifications prescribed for Drug Inspectors of ASU drugs vary. The Inspector may be
a graduate in Pharmacy/ Pharmaceutical Chemistry/ Medicine (with specialization in Clinical
pharmacology or Microbiology) having undergone practical training in the manufacture of
ASU drugs or having a Degree/Diploma in A/S/U systems of medicines or possessing Degree
in Ayurveda Pharmacy as per the provisions of the Act and Rules thereunder. Under such
circumstances when the qualifications and experience levels of inspectors vary, it is important
to impart comprehensive knowledge of the D&C Act and Rules thereunder to the inspectors for
facilitating uniform implementation of the Act. This is all more important as there is no induction
training when the person with requisite qualification is assigned the job of an inspector. In many
of the States, due to lack of dedicated manpower for enforcement of provisions of Drugs &
Cosmetics Act, ASU doctors working in the Hospitals/ Dispensaries are designated as inspectors
usually without any additional capacity building training specifically on analytical aspects. In
such a situation this manual becomes even more essential.
This inspection manual covering various aspects about the qualifications, duties and responsibilities
of inspectors will be a much needed helpful guide for orientation of ASU inspectors for proper
discharge of their duties under D&C Act and Rules thereunder. The Guidelines for Inspection
of GMP compliance by ASU drug industry are especially explained in detail for development of
insight of the inspectors regarding interpretation and implementation of the Rules. This manual
is expected to assist State Licensing Authorities to augment the regulatory capacities of inspectors
and develop master trainers as well.

Chapter I
GMP: An Overview
1. GMP
Good Manufacturing Practice(GMP) is a production and testing practice that helps to ensure
a quality product. GMP guidelines are not prescriptive instructions on how to manufacture
products. These are a series of general principles that must be observed during manufacturing.
When a company is setting up its quality program and manufacturing process, there may be
many ways it can fulfill GMP requirements. It is the companys responsibility to determine the
most effective and efficient quality process.
The Good Manufacturing Practices for ASU Drugs as described in Rule 157 of Drugs & Cosmetics
Rules 1945 with conditions as specified in Schedule T / GMP are to ensure that:
(I) Raw materials used in the manufacture of drugs are authentic, of prescribed quality
and are free from contamination
(II) The manufacturing process is as has been prescribed to maintain the standards
(III) Adequate quality control measures are adopted
(IV) The manufactured drug which is released for sale is of acceptable quality
(V) To achieve the objectives listed above, each licensee shall evolve methodology and
procedures for following the prescribed process of manufacture of drugs which should
be documented as a manual and kept for reference and inspection. However, under
IMCC Act, 1970 registered Vaidyas, Siddhas and Hakeems who prepare medicines
on their own to dispense to their patients and not selling such drugs in the market are
exempted from the purview of Good manufacturing Practice (GMP)

2.

Importance of GMP

Unlike conventional pharmaceutical products, which are usually produced from synthetic
materials by means of reproducible manufacturing techniques and procedures, ASU medicines
are mainly prepared from materials of herbal origin, which are often obtained from varied
geographical and/or commercial sources. As a result it may not always be possible to ascertain
2

the conditions to which they may have been subjected. In addition, they may vary in composition
and properties. Furthermore, the procedures and techniques used in the manufacture and quality
control of ASU medicines are often substantially different from those employed for conventional
pharmaceutical products.
Because of the inherent complexity of naturally grown medicinal plants and the often variable
nature of cultivated ones, the examples of contamination with toxic medicinal plants and/ or
plant parts and the number and small quantity of defined active ingredients, the production
and primary processing has a direct influence on the quality of ASU medicines. For this reason,
application of GMPs in the manufacture of ASU medicines is an essential tool to assure their
quality.

3.

Basic Principles of GMP

Many countries have legislated that pharmaceutical and medical device companies must
follow GMP procedures, and have created their own GMP guidelines that correspond with
their legislation. Basic concepts of all of these guidelines remain more or less similar to the
ultimate goals of safeguarding the health of the patient as well as producing good quality
medicine.
Although there are a number of them, all guidelines follow a few basic principles:

Manufacturing processes are clearly defined and controlled. All critical processes are
validated to ensure consistency and compliance with specifications.

Manufacturing processes are controlled, and any changes to the process are evaluated.
Changes that have an impact on the quality of the drug are validated as necessary.

Instructions and procedures are written in clear and unambiguous language.

Operators are trained to carry out and document procedures.

Records are made manually or by instruments during manufacture that demonstrate

that all the steps required by the defined procedures and instructions were in fact
taken and that the quantity and quality of the drug was as expected. Deviations are
investigated and documented.

Records of manufacture (including distribution) that enable the complete history of a

batch to be traced are retained in a comprehensible and accessible form.
3

A system is available for recalling any batch of drug from sale or supply.

Complaints about marketed drugs are examined, the causes of quality defects are
investigated, and appropriate measures are taken with respect to the defective drugs
and to prevent recurrence.

There may be many ways for a company to fulfil the GMP requirements while setting up its
quality program and manufacturing process. It is the companys responsibility to determine the
most effective and efficient quality process.

4.

Legal provisions for GMP

The legal provisions related to GMP are described under Drugs and Cosmetics Rules 1945,
particularly Rule 151 to 160 and Schedule T.

5.

Roles and responsibilities of Inspectors conducting GMP inspection

The powers which may be exercised by an Inspector and the duties which may be
performed by him and the conditions, limitations, or restrictions subject to which such
powers and duties may be exercised or performed shall be such as may be prescribed in
Drugs & Cosmetics Act 1940 and Rules thereunder.
In relation to Ayurvedic, Siddha or Unani drug, an inspector appointed by the Central
Government or a State Government under section 33G of Drugs & Cosmetics Act 1940 is
called as Inspector.
A person with any of the following qualifications can be appointed as an Inspector:
(a) Degree in Pharmacy/ Pharmaceutical Sciences/ Medicine with specialization in
Clinical pharmacology or Microbiology from a University established in India by
law and shall have undergone practical training in the manufacture of Ayurvedic
(including Siddha) or Unani drug, as the case may be; or
(b) Degree in Ayurvedic or Siddha or Unani System or a degree in Ayurveda Pharmacy,
as the case may be, conferred by a University or State Government or a Statutory
Faculty, Council or Board of Indian Systems of Medicine recognized by the Central
Government or the State Government for this purpose; or
(c) Diploma in Ayurveda, Siddha or Unani Systems, as the case may be, granted by a
State Government or an Institution recognized by the Central Government or a State
Government for this purpose.
4

Drugs & Cosmetics Rule 167and 49 may be seen for details.

Any person having any financial interest in the manufacture or sale of any drug cannot be
appointed as Inspector in spite of meeting above requirements.
Duties regarding regulation of manufacture for sale of ASU drugs
Subject to the provisions of section 23 and of any rules made by the Central Government in
this behalf, an Inspector may, within the local limits of the area for which he is appointed
Inspect,
(i)

any premises wherein any ASU drugs is being manufactured and the means employed
for standardizing and testing the ASU drugs;

(ii) any premises wherein any ASU drugs is being sold, or stocked or exhibited or offered
for sale, or distributed .
Take samples of any ASU drug,
(i)

which is being manufactured or being sold or is stocked or exhibited or offered for

sale, or is being distributed;

(ii) from any person who is in the course of conveying, delivering or preparing to deliver
such ASU drugs to a purchaser or a consignee.
At all reasonable times, with such assistance, if any, as he considers necessary,
(i)

search any person, who, he has reason to believe, has secreted about his person, any
ASU drugs in respect of which an offence under Chapter IV-A of D&C Act has been,
or is being, committed; or

(ii) enter and search any place in which he has reason to believe that an offence under
Chapter IV-A of D&C Act has been, or is being committed; or
(iii) stop and search any vehicle, vessel, or other conveyance which, he has reason to
believe, is being used for carrying any ASU drug in respect of which an offence under
Chapter IV-A of D&C Act has been, or is being, committed, and order in writing the
person in possession of the ASU drugs in respect of which the offence has been, or is
being, committed, not to dispose of any stock of such ASU drugs for a specified period
5

not exceeding twenty days, or, unless the alleged offence is such that the defect may
be removed by the possessor of the ASU drugs, seize the stock of such ASU drugs
and any substance or article by means of which the offence has been ,or is being,
committed or which may be employed for the commission of such offence. (Clause c
of Section 22 of D&C Act 1940)
Examine any record, register, document or any other material object found with any
person, or in place, vehicle, vessel or other conveyance referred as above and seize the
same if he has reason to believe that it may furnish evidence of the commission of an
offence punishable under this Act or the Rules made thereunder.
A receipt by an Inspector for the stock of any ASU drugs or any record, register,
document or any other material object seized by him shall be in Form 16 of Drugs &
Cosmetics Rules 1945.
Require any person to produce any record, register, or other document relating to
the manufacture for sale or for distribution, stocking, exhibition for sale, offer for sale
or distribution of any ASU drugs in respect of which he has reason to believe that an
offence under Chapter IV-A of D&C Act has been, or is being, committed.
Exercise such other powers as may be necessary for carrying out the purposes of
Chapter IV-A of D&C Act or any rules made there under.
The provisions of the Code of Criminal Procedure, 1973 shall, so far as may be, apply
to any search or seizure under Chapter IV-A of D&C Act as they apply to any search
or seizure made under the authority of a warrant issued under section 94 of the said
Code.
Every record, register or other document seized or produced as above shall be returned
to the person, from whom they were seized or who produce the same, within a period
of twenty days of the date of such seizure or production, as the case may be, after
copies thereof or extracts there from certified by that person, in such manner as may
be prescribed, have been taken.
If any person wilfully obstructs an Inspector in the exercise of the powers conferred
upon him by or under Chapter IV-A of D&C Act or refuses to produce any record,
register or other document when so required as mentioned above, he shall be
punishable with imprisonment which may extend to three years, or with fine, or with
both.

Subject to the instructions of the controlling authority, it shall be the duty of an Inspector
authorized to inspect the manufacture of Ayurvedic (including Siddha) or Unani drugs
(i)

to inspect not less than twice a year, all premises licensed for manufacture of
Ayurvedic (including Siddha) or Unani drugs within the area allotted to him and to
satisfy himself that the conditions of the license and the provisions of the Act and the
Rules made thereunder are being observed;

(ii) to send forth with to the controlling authority after each inspection a detailed report
indicating whether or not the conditions of the license and the provisions of the Act
and rules made thereunder are being observed;
(iii) to take samples of the drugs manufactured on the premises and send them for test or
analysis in accordance with these Rules;
(iv) to institute prosecutions in respect of violation of the Act and the Rules made
thereunder.
Every inspector shall be deemed to be a public servant within the meaning of section
21 of the Indian penal Code and shall be officially sub-ordinate to such authority as the
Government appointing him may specify in this behalf.
The Central Government or a State Government may, by notification in the Official Gazette,
appoint such persons as it think fit, having the prescribed qualifications, to be Inspectors for
such areas as may be assigned to them by the Central Government or the State Government,
as the case may be.
Standard procedure for drug sample collection by a Drug Inspector
Where an Inspector takes any sample of an ASU drugs under Chapter IV-A of D&C
Act, he shall tender the fair price thereof and may require a written acknowledgement
therefor.
Where the price tendered is refused, or where the Inspector seizes the stock of any
ASU drugs, he shall tender a receipt therefore in the Form 17A of Drugs & Cosmetics
Rules 1945.
Where an Inspector takes a sample of a ASU drugs for the purpose of test or analysis,
he shall intimate such purpose in writing in the Form 17 of Drugs & Cosmetics Rules
1945, to the person from whom he takes it and, in the presence of such person unless
he wilfully absents himself, shall divide the sample into four portions and effectively
7

seal and suitably mark the same and permit such person to add his own seal and mark
to all or any of the portions so sealed and marked:

Provided that where the sample is taken from premises whereon the ASU drug is
being manufactured, it shall be necessary to divide the sample into three portions
only:

Provided further that where the ASU drugs is made up in containers of small volume,
instead of dividing a sample as aforesaid, the Inspector may, and if the ASU drugs be
such that it is likely to deteriorate or be otherwise damaged by exposure shall, take
three or four, as the case may be, of the said containers after suitably marking the
same and, where necessary, sealing them.

The Inspector shall restore one portion of a sample so divided or one container, as the
case may be, to the person from whom he takes it, and shall retain the remainder and
dispose of the same as follows:
(i)

one portion or container he shall forthwith send to the Government Analyst for test or
analysis.

(The Sample for test or analysis to be sent to the Government Analyst shall be sent by
registered post or by hand in a sealed package, enclosed together with a memorandum
in Form 18-A of Drugs & Cosmetics Rules 1945, in an outer addressed to the Government
Analyst. The package as well as the outer cover shall be marked with a distinguishing
number. A copy of the memorandum and a specimen impression of the seal used
to seal the package shall be sent by registered post or by hand to the Government
Analyst. On the receipt of the package from an Inspector, the Government Analyst or
an Officer authorized by him in writing in his behalf shall open the package and shall
also record the conditions of the seals on the package).

(ii) the second he shall produce to the Court before which proceedings, if any, are
instituted in respect of the ASU drugs;
(iii) the third, where taken, he shall send to the person, if any, whose name, address and
other particulars have been disclosed under section 18A.

(Section 18A Every person, not being the manufacturer of a ASU drugs or his
agent for the distribution thereof, shall, if so required, disclose to the Inspector the
name, address and other particulars of the person from whom he acquired the drug
or cosmetic.)
8

 Where an Inspector takes any action under clause (c) of section 22,
(i)

he shall use all despatch in ascertaining whether or not the ASU drugs contravenes
any of the provisions of the section 33EEC and, if it is ascertained that the ASU drugs
does not so contravene, forthwith revoke the order passed under the said clause or,
as the case may be take , such action as may be necessary for the return of the stock
seized;

(ii) if he seizes the stock of the ASU drugs, he shall as soon as may be, inform a Judicial
Magistrate and take his orders as to the custody thereof;
(iii) without prejudice to the institution of any prosecution, if the alleged contravention be
such that the defect may be remedied by the possessor of the ASU drugs, he shall, on
being satisfied that the defect has been so remedied, forthwith revoke his order under
the said clause.
Where an Inspector seizes any record, register, document or any other material object,
he shall, as soon as may be, inform a Judicial Magistrate and take his orders as to the
custody thereof.
Duties Regarding Joint Inspection for Approval of Drug Testing laboratories under Rule
160A-J
Before an approval in Form 48 is granted, the approving authority shall cause the
laboratory at which the testing of Ayurvedic, Siddha and Unani drugs as the case may
be, is proposed to be carried out to be inspected jointly by the Inspectors appointed
or designated by the Central Government and State Government for this purpose,
who shall examine the premises and the equipment intended to be used for testing of
drugs and verify into the professional qualifications of the expert staff who are or may
be employed by the laboratory.
Report of inspection. - The Inspectors appointed by the Central Government as stated
in Rule 160-E shall forward to the approving authority a detailed report of the results
of the inspection.
The approved laboratory shall allow the Inspector appointed under the Act to enter
with or without prior notice the premises where testing is carried out and to inspect the
premises and the equipment used for test and the testing procedures employed. The
laboratory shall allow the Inspectors to inspect the registers and records maintained
under these rules and shall supply to such Inspectors such information as they may
9

require for the purpose of ascertaining whether the provisions of the Act and rules
made thereunder have been observed.

6.

Role of the Licensing Authority regarding GMP certification

The licensing authority notified by the State Government is responsible for enforcing all the
provisions of D&C Rules 1945 related to issue of GMP certification. The detailed provisions
will follow in next few pages.

10

Chapter II
Legal provisions for GMP certification
Rules as in Drugs & Cosmetics Rules 1945 regarding
Manufacture for Sale of Ayurvedic (including Siddha) or Unani Drugs
(Part XVI of D&C Rules 1945)

151. Manufacture on more than one set of premises

If Ayurvedic (including Siddha) or Unani drugs are manufactured on more than one set of
premises, a separate application shall be made and a separate licence shall be obtained in
respect of each such set of premises.

152. Licensing Authorities

For this purpose of this Part the State Government shall appoint such Licensing Authorities
and for such areas as may be specified in this behalf by notification in the Official Gazette.

153. Application for licence to manufacture Ayurvedic (including Siddha) or

Unani drugs.
(1) An application for the grant or renewal of a licence to manufacture for sale any
Ayurvedic (including Siddha) or Unani drugs shall be made in Form 24-D to the
Licensing Authority along with a fee of rupees one thousand:

Provided that in the case of renewal the applicant may apply for the renewal of the
licence before its expiry or within one month of such expiry:

Provided further that the applicant may apply for renewal after the expiry of one
month but within three months of such expiry in which case the fee payable for renewal
of such licence shall be rupees one thousand and two hundred plus an additional fee
of rupees six hundred..

11

(2) A fee of rupees three hundred shall be payable for a duplicate copy of a licence issued
under this rule, if the original licence is defaced, damaged or lost.
153-A Loan Licence
(i)

An application for the grant or renewal of a loan licence to manufacture for sale of
any Ayurvedic (including Siddha) or Unani drugs shall be made in Form 24-E to the
Licensing Authority along with a fee of rupees six hundred.

ExplanationFor the purpose of this rule, a loan licence means a licence which a
Licensing Authority may issue to an applicant who does not have his own arrangements
for manufacture but intends to avail himself of the manufacturing facilities owned by
a licence in Form 25-D:

PROVIDED that in the case of renewal the applicant may apply for the renewal of the
licence before its expiry or within one month of such expiry:

PROVIDED further that the applicant may apply for renewal after the expiry of one
month, but within three months of such expiry in which case the fee payable for
renewal of such licence shall be rupees six hundred plus an additional fee of rupees
three hundred.

(ii) A fee of rupees one hundred and fifty shall be payable for a duplicate copy of a licence
issued under this rule, if the original licence is defaced, damaged or lost.

154. Form of licence to manufacture Ayurvedic (including Siddha) or Unani drugs

(1) Subject to the conditions of rule 157 being fulfilled, a licence to manufacture for sale
any Ayurvedic (including Siddha) or Unani drugs shall be issued in Form 25-D. The
licence shall be issued within a period of three months from the date of receipt of the
application.
(2) A licence under this rule shall be granted by the licensing authority after consulting
such expert in Ayurvedic (including Siddha) or Unani Systems of medicine as the case
may be, which the State Government may approve in this behalf.

12

154-A Form of loan licence to manufacture for sale of Ayurvedic (including Siddha) or
Unani drugs
(i)

A loan licence to manufacture for sale of any Ayurvedic (including Siddha) or Unani
drugs shall be issued in Form 25E.

(ii) A licence under this rule shall be granted by the Licensing Authority after consulting
such expert in Ayurvedic (including Siddha) or Unani systems of medicine, as the
case may be, which the State Government may approve in this behalf.
(iii) The Licensing Authority shall, before the grant of a loan licence, satisfy himself that
the manufacturing unit has adequate equipment, staff, capacity for manufacture and
facilities for testing, to undertake the manufacture on behalf of the applicant for a loan
licence.

155. Certificate of renewal

The certificate of renewal of a licence in Form 25-D shall be issued in Form 26-D.
155-A Certificate of renewal of a loan licence
The certificate of renewal of a loan licence in Form 25-E shall be issued in Form 26-E.
155-B Certificate of award of G.M.P. of Ayurveda, Siddha and Unani Drugs
(i)

The certificate of Good Manufacturing Practices to manufacturers of Ayurveda,

Siddha or Unani drugs shall be issued for a period of five years to licensees who
comply with the requirements of Good Manufacturing Practices (GMP) of Ayurveda,
Siddha and Unani drugs as laid down in Schedule T.

(ii) The certificate referred to in sub rule (1) shall be issued for a period of five years from
the date of issuance of the license.

156. Duration of licence

An original licence in Form 25-D or a renewed license in Form 26-D, unless sooner suspended
or cancelled shall be valid for a period of five years from the date of its issue or renewed.

13

PROVIDED that if the application for the renewal of a licence is made before its expiry
or within one month of its expiry, or if the application is made within three months of its
expiry after payment of the additional fee of rupees five hundred, the licence shall continue
to be in force until orders are passed on the application. The licence shall be deemed to have
expired, if the application for its renewal is not made within three months of its expiry.
156-A Duration of loan licence
An original loan licence in Form 25-E or a renewed loan licence in Form 26-E, unless sooner
suspended or cancelled, shall be valid for a period of five years from the date of its issue
or renewed:
PROVIDED that if the application for the renewal of a loan licence is made in accordance
with rule 153-A, the loan licence shall continue to be in force until orders are passed on the
application. The licence shall be deemed to have expired, if the application for its renewal
is not made within three months of its expiry.

157. Conditions for the grant or renewal of a licence in Form 25-D

Before a licence in Form 25-D is granted or renewed in Form 26-D the following conditions
shall be complied with by the applicant, namely
(1) The manufacture of Ayurvedic (including Siddha) or Unani drugs shall be carried out
in such premises and under such hygienic conditions as are specified in Schedule T.
(a) For issuing of the certificate of Good Manufacturing Practices, the Licensing Authority
shall verify the requirements as per Schedule T and issue the Good Manufacturing
Practices certificate in Form 26 E-I, simultaneously along with grant or renewal of
License in Form 25-D.
(2) The manufacture of Ayurvedic (including Siddha) or Unani drugs shall be conducted
under the direction and supervision of competent technical staff consisting at least one
person, who is a whole time employee and who possesses the following qualifications,
namely
(a) A degree in Ayurveda or Ayurvedic Pharmacy, Siddha or Unani system of medicine,
as the case may be, conferred by a University, a State Government or Statutory
14

Faculties, Councils and Boards of Indian Systems of medicines recognized by the

Central Government or a State Government for this purpose, or
(b) A diploma in Ayurveda, Siddha or Unani system of medicine granted by a State
Government or an Institution recognised by the Central Government for this purpose, or
(c) A graduate in Pharmacy or Pharmaceutical Chemistry or Chemistry or Botany of a
University recognized by the Central Government with experience of at least two
years in the manufacture of drugs pertaining to the Ayurvedic or Siddha or Unani
systems of medicines, or
(d) A Vaid or Hakim registered in a State Register of Practitioners of indigenous systems
of medicines having experience of at least four years in the manufacture of Ayurvedic
or Siddha or Unani drugs, or
(e) A qualification as Pharmacist in Ayurvedic (including Siddha) or Unani systems of
medicine, possessing experience of not less than eight years in the manufacture of
Ayurvedic or Siddha or Unani drugs as may be recognized by the Central Government.
(3) The competent technical staff to direct and supervise the manufacture of Ayurvedic
drugs shall have qualifications in Ayurveda and the competent technical staff to
direct and supervise the manufacture if Siddha drugs and Unani drugs shall have
qualification in Siddha or Unani, as the case may be.
157-A Maintaining of records of raw material used by licensed manufacturing unit of Ayurveda,
Siddha and Unani drugs in the preceding financial year
Each licensed manufacturing unit of Ayurveda or Siddha or Unani drugs shall keep a
record of raw material used by each licensed manufacturing unit of Ayurveda, Siddha or
Unani drugs, as the case may be in the proforma given in Schedule TA in respect of all raw
materials utilized by that unit in the manufacture of Ayurveda or Siddha or Unani drugs
in the preceding financial year, and shall submit the same by the 30th day of June of the
succeeding financial year to the State Drug Licensing Authority of Ayurveda, Siddha and
Unani drugs and to the National Medicinal Plants Board or any agency nominated by the
National Medicinal Plants Board for this purpose.

15

158. Conditions of licence

A licence in Form 25-D shall be subject to the conditions stated therein and to the following
further conditions, namely
(a) The licensee shall maintain proper records of the details of manufacture and of the
tests, if any, carried out by him, or by any other person on his behalf, of the raw
material and finished products.
(b) The licensee shall allow an Inspector appointed under the Act to enter any premises
where the manufacture of a substance in respect of which the licence is issued is
carried on, to inspect the premises, to take samples of the raw material as well as
finished products, and to inspect the records maintained under these rules.
(c) The licensee shall maintain an Inspection Book in Form 35 to enable an Inspector to
record his impressions and the defects noticed.
158-A Conditions of loan licence
A licence in Form 25-E shall be subject to the following further conditions, namely:
(i)

The licence in Form 25-E shall be deemed to be cancelled or suspended, if the licence
owned by the licensee in Form 25-D whose manufacturing facilities have been availed
of by the licensee is cancelled or suspended, as the case may be, under these rules.

(ii) The licensee shall comply with the provisions of the Act and of the Rules and with
such further requirements if any, as may be specified in any Rules subsequently made
under Chapter IV-A of the Act, provided that where such further, requirements are
specified in the Rules; these would come into force four months after publication in
the Official Gazette.
(iii) The licensee shall maintain proper records of the details of manufacture and of the
tests, if any, carried out by him, or any other person on his behalf, of the raw materials
and finished products.
(iv) The licensee shall allow an Inspector appointed under the Act to inspect all registers
and records maintained under these rules and shall supply to the Inspector such
information as he may require for the purpose of ascertaining whether the provisions
of the Act and the Rules have been observed.
16

(v) The licensee shall maintain an Inspection Book in form 35 to enable an Inspector to
record his impressions and the defects noticed.
158-B Guidelines for issue of license with respect to Ayurveda, Siddha or Unani drugs
I.

(A) Ayurveda, Siddha Unani Medicines under section 3 (a):-

Ayurveda, Siddha or Unani drugs includes all medicines intended for internal or
external use for or in the diagnosis, treatment, mitigation or prevention of disease or
disorder in human beings or animals, and manufactured exclusively in accordance
with the formulae described in the authoritative books of Ayurvedic, Siddha and
Unani Tibb system of medicine, as specific in the First Schedule;

(B). Patent or Proprietary medicine under section 3(h);

(i)

In relation to Ayurvedic, Siddha and Unani Tibb system of medicine of all

formulations containing only such ingredients mentioned in the formulae described
in the authoritative books of Ayurveda, Siddha or Unani Tibb system of medicines
specified in the First Schedule, but does not include a medicine which is administrated
by parenteral route and also a formulation included in the authoritative books as
specified in clause (a);

(ii) Balya/Poshak/Muqawi/Unavuporutkal/positive health promoter formulations having

ingredients mentioned in books of First Schedule of the Drugs and Cosmetics Act and
recommended for promotional and preventive health.
(iii) Saundarya Prasadak (Husane afza)/Azhag-sadhan formulations having ingredients
mentioned in Books of First Schedule of the Drugs and Cosmetics Act and recommended
for oral,skin, hair and body care.
(iv) Aushadh Ghana (medicinal Plant extracts dry/wet) extract obtained from plant
mentioned in books of First Schedule of the Act including Aqueous or hydro-alcohol.
II. (A) For issue of license to the medicine with respect to Ayurvedic, Siddha or
Unani, the conditions relating to safety study and the experience or evidence of
effectiveness shall be such as specified in columns (5) and (6) of the Table given
below:-

17

S.
No.

Category

Ingredient(S)

Indication(S)

Safety study

Experience/Evidence of
Effectiveness
Published
Literature

Proof of
Effectiveness

1.

(A) Ayurveda, Siddha And

Unani drugs. Given in
158-B as referred in 3(a)

As per text

As per text

Not Required

Required

Not Required

2.

(B) Any change in dosage

form of Ayurveda, Siddha and
Unani drugs as described in
As per text
section 3(a) of the Drugs and
Cosmetics Act, 1940

As per text

Not Required

Required

Not Required

3.

(C) Ayurveda, Siddha And

Unani drugs referred in 3(a) to As per text
be used for new indication

New

Not Required

If Required

Required

II. B For issue of license with respect to Patent or Proprietary medicine. The condition
relating to Safety studies and experience or evidence of effectiveness specified as
follows:S.
No.

Category

Ingredient(S)

Indication(S) Safety study

Experience/Evidence of
Effectiveness

1.

Patent or Proprietary
medicine

As per text

Textual
rationale

Not Required

Of
Ingredients

*Pilot study as
per relevant
protocol for
Ayurveda,
Siddha and
Unani drugs.

2.

Ayurveda, Siddha and

Unani drug with any of the
ingredients of Schedule E (1)
of The Drugs and Cosmetics
Act, 1940.

As per text

Existing

Required

Required

Required

(III) For issue of license with respect to Balya and Poshak medicines the person who
applies for license is required to submit the following:
(i)

Photo-copy of the textual reference of ingredients used in the formulation as

mentioned in the book of 1st Schedule;

(ii) Conduct safety studies in case the product contains of any of the ingredients as
specified in the Schedule E (1), as per the guidelines for evaluation of Ayurveda,
Siddha and Unani Drugs formulations;

18

(iii) For textual indications the safety and effectiveness study is not required.
(IV) For issue of license with respect to Saundarya Prasadak (Husane afza/Azhagu
Sodhan) the person who applied for license required to:(i)

Submit photo copy of the textual reference of ingredients used in the formulation as
mentioned in the book of 1st schedule;

(ii) Conduct safety studies, in case the formulation contains of any of the ingredients
as specified in the Schedule E (1), as per the guidelines for evaluation of Ayurveda,
Siddha and Unani formulation;
(iii) For textual indications the safety and effectiveness study is not required.
(V) For issue of license with respect to medicine Ausadh Ghana [extract of/medicinal
plant (dry or wet).
S.
No.

Category

Ingredient (S) Indication (s)

Safety study

Experience/Evidence of
Effectiveness
Published
Literature

Proof of
Effectiveness

1.

(A) Aqueous

As per Text

As per Text

Not Required

Not Required Not Required

2.

(A1). Aqueous

As per Text

New
indication

Not Required

Not Required Required

3.

(B) Hydro-Alcohol

As per Text

As per Text

Not Required

If Required

Not Required

4.

(B1) Hydro-Alcohol

As specified

New
Indication**

Required

If Required

Required

5.

Other than Hydro/

Hydro-Alcohol

As specified

As specified

Required
If Required
Acute, Chronic,
Mutagenicity
and
Teratogenicity

Required

*The standard protocol will also include concept of Anupan, Prakriti & Tridosh etc.
published by Central Research Councils Ayurveda, Siddha, Unani and other Government/
Research Bodies.
**New indication means which is other than mentioned in 1st schedule books of Drugs and
Cosmetics Act 1940.
19

159. Cancellation suspension of licences

(1) The Licensing Authority may, after giving the licensee an opportunity to show cause
within a period which shall not be less than fifteen days from the date of receipt of
such notice, why such an order should not be passed, by an order in writing stating
the reasons therefore, cancel a licence issued under this Part or suspend it for such
period as he thinks fit, either wholly or in respect of some of the drugs to which it
relates, if in his opinion, the licensee has failed to comply with any of the conditions
of the licence or with any provisions of the Act and the Rules made thereunder.
(2) A licensee whose licence has been suspended or cancelled may appeal to the State
Government within a period of three months from the date of receipt of the order
which shall, after considering the appeal, decide the same.

160. Identification of raw materials

Raw materials used in the preparation of Ayurvedic (including Siddha) or Unani drugs
shall be identified and tested, wherever test are available for their genuineness, and records
of such tests as are carried out for the purpose and the methods thereof shall be maintained.

20

SCHEDULE T
[See Rule 157]

Good manufacturing practices for ayurvedic,

siddha and unani medicines
The Good Manufacturing Practices (GMP) are prescribed as follows in Part I and Part II toensure
that:
(i)

Raw materials used in the manufacture of drugs are authentic, of prescribed quality and are
free from contamination.

(ii) The manufacturing process is as has been prescribed to maintain the standards.
(iii) Adequate quality control measures are adopted.
(iv) The manufactured drug which is released for sale is of acceptable quality.
(v) To achieve the objectives listed above, each licensee shall evolve methodology and
procedures for following the prescribed process of manufacture of drugs which should
be documented as a manual and kept for reference and inspection. However, under IMCC
Act 1970 registered Vaidyas, Siddhas and Hakeems who prepare medicines on their own to
dispense to their patients and not selling such drugs in the market are exempted from the
purview of G.M.P.

PART-I
Good manufactring practices
Factory Premises:
The manufacturing plant should have adequate space for:

(i)

Receiving and storing raw material;

(ii)

Manufacturing process areas;

21

(iii)

Quality control section;

(iv

Finished goods store;

(v)

Office;

(vi)

Rejected goods/drugs store.

1.1

General Requirements:

1.1(A) Location and surroundings- The factory building for manufacture of Ayurveda, Siddha
and Unani medicines shall be so situated and shall have such construction as to avoid
contamination from open sewerage, drain, public lavatory or any factory which produces
disagreeable or obnoxious odour or fumes or excessive soot, dust or smoke.
1.1(B) Buildings- The building used for factory shall be such as to permit production of drugs
under hygienic conditions and should be free from cobwebs and insects/rodents. It should
have adequate provision of light and ventilation. The floor and the walls should not be
damp or moist. The premises used for manufacturing, processing, packaging and labelling
will be in conformity with the provisions of the Factory Act. It shall be located so as to be:
(i) Compatible with other manufacturing operations that may be carried out in the
same or adjacent premises.
(ii) Adequately provided with working space to allow orderly and logical placement
of equipment and materials to avoid the risk of mix-up between different drugs or
components thereof and control the possibility of cross- contamination by other drugs
or substances and avoid the risk of omission of any manufacturing or control step.
(iii) Designed, constructed and maintained to prevent entry of insects and rodents. Interior
surface (walls, floors and ceilings) shall be smooth and free from cracks and permit
easy cleaning and disinfection. The walls of the room in which the manufacturing
operations are carried out shall be impervious to and be capable of being kept clean.
The flooring shall be smooth and even and shall be such as not to permit retention or
accumulation of dust or waste products.
(iv) Provided with proper drainage system in the processing area. The sanitary fittings
and electrical fixtures in the manufacturing area shall be proper and safe.

22

(v) Furnace/Bhatti section could be covered with tin roof and proper ventilation, but
sufficient care should be taken to prevent flies and dust.
(vi) There should be fire safety measures and proper exits should be there.
(vii) Drying space- There should be separate space for drying of raw material, in process
medicine or medicines which require drying before packing. This space will be
protected from flies/insects/dusts, etc., by proper flooring, wire-mash window,
glass pans or other material.
1.1(C) Water Supply- The water used in manufacture shall be pure and of potable quality.
Adequate provision of water for washing the premises shall be made.
1.1(D) Disposal of Waste- From the manufacturing sections and laboratories the waste water and
the residues which might be prejudicial to the workers or public health shall be disposed
off after suitable treatment as per guidelines of pollution control authorities to render them
harmless.
1.1(E) Containers Cleaning- In factories where operations involving the use of containers such
as glass bottles, vials and jars are conducted, there shall be adequate arrangement
separated from the manufacturing operations for washing, cleaning and drying of such
containers.
1.1(F) Stores- Storage should have proper ventilation and shall be free from dampness. It should
provide independent adequate space for storage of different types of material, such as raw
material, packaging material and finished products.
1.1(F)(A) Raw Materials- All raw materials procured for manufacturing will be stored in the
raw materials store. The manufacture based on the experience and the characteristics of
the particular raw material used in Ayurveda, Siddha and Unani system shall decide the
use of appropriate containers which would protect the quality of the raw material as well
as prevent it from damage due to dampness, microbiological contamination or rodent
and insect infestation, etc. If certain raw materials require such controlled environmental
conditions, the raw materials stores may be sub-divided with proper enclosures to provide
such conditions by suitable cabinization. While designing such containers, cabins or areas
in the raw materials store, care may be taken to handle the following different categories
of raw materials:-

23

(1)

Raw material of metallic origin.

(2)

Raw material of mineral origin.

(3)

Raw material from animal source.

(4)

Fresh Herbs.

(5)

Dry Herbs or plant parts.

(6)

Excipients, etc.

(7)

Volatile oils/perfumes & flavours.

(8)

Plant concentrates/extracts and exudates/resins.

Each container used for raw material storage shall be properly identified with the label
which indicates name of the raw material, source of supply and will also clearly state the
status of raw material such as UNDER TEST or APPROVED or REJECTED. The labels
shall further indicate the identity of the particular supply in the form of Batch No. or
Lot. No. and the date of receipt of consignment.
All the raw materials shall be sampled and got tested either by the in-house Ayurvedic,
Siddha and Unani experts (Quality control technical person) or by the laboratories
approved by Government and shall be used only on approval after verifying. The rejected
raw material should be removed from other raw materials store and should be kept in
a separate room. Procedure of First in first out should be adopted for raw materials
wherever necessary. Records of the receipt, testing and approval or rejection and use of
raw material shall be maintained.
1.1(F)(B) Packaging Materials- All packaging materials such as bottles, jars, capsules, etc.
shall be stored properly. All containers and closures shall be adequately cleaned and dried
before packing the products.
1.1(F)(C) Finished Goods Stores- The finished goods transferred from the production area
after proper packaging shall be stored in the finished goods stores within an area marked
Quarantine. After the quality control laboratory and the experts have checked the
correctness of finished goods with reference to its packing/labelling as well as the finished
product quality as prescribed,, then it will be moved to Approved Finished Goods Stock
24

area. Only approved finished goods shall be dispatched as per marketing requirements.
Distribution records shall be maintained as required. If any Ayurvedic, Siddha and Unani
drug needs special storage conditions, finished goods store shall provide necessary
environmental requirements.
1.1(G) Working Space- The manufacturing area shall provide adequate space (manufacture and
quality control) for orderly placement of equipment and material used in any of the
operations for which these are employed so as to facilitate easy and safe working and
to minimize or to eliminate any risk of mix-up between different drugs, raw materials
and to prevent the possibility of cross-contamination of one drug by another drug that is
manufactured, stored or handled in the same premises.
1.1(H) Health, Clothing, Sanitation and Hygiene of Workers- All workers employed in the
Factory shall be free from contagious diseases. The clothing of the workers shall consist
of proper uniform suitable to the nature of work and the climate and shall be clean.
The uniform shall also include cloth or synthetic covering for hands, feet and head
wherever required. Adequate facilities for personal cleanliness such as clean towels, soap
and scrubbing brushes shall be provided. Separate provision shall be made for lavatories to
be used by men and women, and such lavatories shall be located at places separated from
the processing rooms. Workers will also be provided facilities for changing their clothes
and to keep their personal belongings.
1.1(I) Medical Services- The manufacturer shall also provide:

(i)

Adequate facilities for first aid;

(ii)

Medical examination of workers at the time of employment and periodical

checkup thereafter by a physician once a year, with particular attention being
devoted to freedom from infections. Records thereof shall be maintained.

1.1(J) Machinery and Equipments- For carrying out manufacturing depending on the size of
operation and the nature of product manufactured, suitable equipment either manually
operated or operated semi-automatically (electrical or team based) or fully automatic
machinery shall be made available. These may include machines for use in the process
of manufacture such as crushing, grinding, powdering, boiling, mashing, burning,
roasting, filtering, drying, filling, labelling and packing, etc. To ensure ease in movement of
workers and orderliness in operations a suitably adequate space will be ensured between
two machines or rows of machines. These machinery and equipments and machinery
recommended is indicated in Part II-A. Proper standard operational procedures (SOPs)
for cleaning maintaining and performance of every machine should be laid down.
25

1.1(K) Batch Manufacturing Records- The licensee shall maintain batch manufacturing record
of each batch of Ayurvedic, Siddha and Unani drugs manufactured irrespective of the
type of product manufactured (classical preparation or patent and proprietary medicines).
Manufacturing records are required to provide and account of the list of raw materials
and their quantities obtained from the store, tests conducted during the various stages
of manufacture like taste, colour, physical characteristics and chemical tests as may be
necessary or indicated in the approved books of Ayurveda, Siddha and Unani mentioned
in the First Schedule of the Drugs and Cosmetics Act, 1940 (23 of 1940). These tests may
include any in-house or pharmacopoeial test adopted by the manufacturer in the raw
material or in the process material and in the finished product. These records shall be
duly signed by Production and Quality Control Personnel respectively. Details of transfer
of manufactured drug to the finished products store including dates and quantity of drugs
transferred along with record of testing of the finished product, if any, and packaging,
records shall be maintained. Only after the manufactured drugs have been verified and
accepted quality shall be allowed to be cleared for sale. It should be essential to maintain the
record of date, manpower, machine and equipments used and to keep in process record of
various shodhana, bhavana, burning in fire and specific grindings in terms of internal use.
1.1(L) Distribution Records- Records of sale and distribution of each batch of Ayurveda, Siddha
and Unani Drugs shall be maintained in order to facilitate prompt and complete recall
of the batch, if necessary. The duration of record keeping should be the date of expiry
of the batch, Certain categories of Ayurvedic, Siddha and Unani medicines like Bhasma,
Rasa, Kupi- pakva, Parpati, Sindura, Karpu/Uppu/Puram, Kushta, Asava-arista, etc. do
not have expiry date, in contrast their efficacy increases with the passage of time. Hence,
records need to be maintained up to 5 years of the exhausting of stock.
1.1(M) Record of Market Complaints- Manufacturers shall maintain a register to record all reports
of market complaints received regarding the products sold in the market. The manufacturer
shall enter all data received on such market complaints, investigations carried out by the
manufacturers regarding the complaint as well as any corrective action initiated to prevent
recurrence of such market complaints shall also be recorded. Once in a period of six months
the manufacturer shall submit the record such complaints to the Licensing Authority. The
Register shall also be available for inspection during any inspection of the premises.

Reports of any adverse reaction resulting from the use of Ayurvedic, Siddha andUnani
drugs shall also be maintained in a separate register by each manufacturer. The
manufacturer shall investigate any of the adverse reaction to find if the same is due to any
defect in the product, and whether such reactions are already reported in the literature or
it is a new observation.

26

1.1(N) Quality Control- Every licensee is required to provide facility for quality control section
in his own premises or through Government-approved testing laboratory. The test shall be
as per the Ayurveda, Siddha and Unani pharmacopoeial standard. Where the tests are not
available, the test should be performed according to the manufacturers specification or
other information available. The quality control section shall verify all the raw materials,
monitor in process, quality checks and control the quality of finished product being
released to finished goods store/warehouse. Preferably for such quality control there will
be a separate expert. The quality control section shall have the following facilities:

(a)

There should be 150 sq feet area for quality control section.

(b)
For identification of raw drugs, reference books and reference samples should be
maintained.

(c)

Manufacturing record should be maintained for the various processes.

(d)

To verify the finished products, controlled samples of finished products of each

batch will be kept till the expiry date of product.

(e)

To supervise and monitor adequacy of conditions under which raw materials, semifinished products and finished products are stored.

(f)

Keep record in establishing shelf life and storage requirements for the drugs.

(g)

Manufacturers who are manufacturing patent proprietary Ayurveda, Siddha and

Unani medicines shall provide their own specification and control references in
respect of such formulated drugs.

(h)

The record of specific method and procedure of preparation, that is, Bhavana,
Mardana and Puta and the record of every process carried out by the
manufacturer shall be maintained.

(i)

The standards for identity, purity and strength as given in respective pharmacopoeias
of Ayurveda, Siddha and Unani systems of medicines published by Government of
India Shall be complied with.

(j)

All raw materials will be monitored for fungal, bacterial contamination with a view
to minimize such contamination.

27

(k) Quality control section will have a minimum of(i)

(a)

Expert in Ayurveda or Siddha or Unani who possess a degree qualification

recognized under Schedule II of Indian Medicine Central Council Act, 1970.

(b)

Chemist, who shall possess at least a Bachelor Degree in Science or

Pharmacy or Pharmacy (Ayurveda) awrded by a recognized University; and

(c)

A Botanist (Pharmacognosist) who shall possess at least a Bachelor Degree

in Science (Medical) or Pharmacy or Pharmacy (Ayurveda) awarded by a
recognized University.

(ii) The manufacturing unit shall have a quality control section as explained under
Section 35(ii). Alternatively, these quality control provisions will be met by getting
testing, etc., from a recognized laboratory for Ayurveda, Siddha and Unani drugs;
under Rule 160-A of the Drugs and Cosmetics Act. The manufacturing company will
maintain all the record of various tests got done from outside recognized laboratory.
(iii) List of equipment recommended is indicated in Part II-C.

1.2

Requirement for Sterile Product:

(A) Manufacturing Areas For the manufacture of sterile Ayurvedic, Unani and Siddha
drugs, separate enclosed areas specifically designed for the purpose shall be provided.
These areas shall be provided with air locks for entry and shall be essentially dust
free and ventilated with an air supply. For all areas where aseptic manufacture has
to be carried out, air supply shall be filtered through bacteria retaining filters (HEPA
Filters) and shall be at a pressure higher than in the adjacent areas. The filters shall
be checked for performance on installation and periodically thereafter the record of
checks shall be maintained. All the surfaces in sterile manufacturing areas shall be
designed to facilitate cleaning and disinfection. For sterile manufacturing routine
microbial counts of all Ayurvedic, Siddha and Unani drug manufacturing areas shall
be carried out during operations. Results of such count shall be checked against
established in-house standards and record maintained. Access to manufacturing areas
shall be restricted to minimum number of authorized personnel. Special procedure to
be followed for entering and leaving the manufacturing areas shall be written down
and displayed. For the manufacturing of Ayurvedic, Siddha and Unani drug that
can be sterilized in their final containers, the design of the areas shall preclude the

28

possibility of the products intended for sterilization being mixed with or taken to be
products already sterilized. In case of terminally sterilized products, the design of the
areas shall preclude the possibility of mix-up between non-sterile products.
(B) Precautions against contamination and mix:
a) Carrying out manufacturing operations in a separate block of adequately isolated
building or operating in an isolated enclosure within the building,
(b) Using appropriate pressure differential in the process area.

Providing a suitable exhaust system.

(d) Designing laminar flow sterile air system for sterile products.
(e) The germicidal efficiency of UV lamps shall be checked and recorded indicating the
burning hours or checked using intensity.
(f) Individual containers of liquids and ophthalmic solutions shall be examined against
black-white background fitted with diffused light after filling to ensure freedom from
contamination with foreign suspended matter.
(g) Expert technical staff approved by the Licensing Authority shall check and compare
actual yield against theoretical yield before final distribution of the batch.
All process controls a s required under master formula including room temperature, relative
humidity, volume filled, leakage and clarity shall be checked and recorded.

29

PART-II
A. List of recommended machinery, equipment and minimum manufacturing premises

required for the manufacture of various categories of ayurvedic, siddha system of
Medicines
One machine indicated for one category of medicine could be used for the manufacturing of other
category of medicine also. Similarly some of the manufacturing areas like powdering, furnace,
packing of liquids and Avaleha, Paks, could also be shared for these items.
S. No.

Category of
Medicine

Minimum manufacturing
space required

Machinery/equipment recommended

1200 Square feet covered

area with separate cabins
or partitions for each
activity. If Unani medicines
are manufactured in same
premises an additional
area of 400 sq. feet will be
required.
1.

Anjana/Pisti

100 sq. feet.

Kharal/mechanized/ motorized Kharal, End

runner/ Ball mill, Sieves/ Shifter.

2.

Churna / Nasya/
Manjan/Lepa/ Kwath
Churn

200 sq feet

Grinder/Disintegrator/Pulveriser/ Powder
mixer/Sieves/Shifter.

3.

Pills/Vati /Gutika
Matirai and tablets

100 sq. feet

Ball Mill, Mass mixer/powder mixer,

Granulator drier, tablet compressing
machine, pill/vati cutting machine, stainless
steel trays/container for storage and sugar
coating, polishing pan in case of sugar-coated
tablets, mechanised chattoo (for mixing
guggulu) where required.

4.

Kupi pakava/Ksara/
Parpati/LavanaBhasma
Satva/Sindura Karpu/
Uppu / Param

150 sq. feet

Bhatti, Karahi/Stainless steel Vessels/

Patila, Flask, Multani Matti/Plaster of Paris,
Copper Rod, Earthen container, Gaj Put
Bhatti, Mufflefurnace(Electrically operated),
End/Edge Runner, Exhaust Fan, Wooden/
S.S.Spatula.

5.

Kajal

100 sq. feet

Earthen lamps for collection of Kajal, Triple

Roller Mill, End Runner, Sieves, S.S.Patila,
Filling/ packing and manufacturing room
should be provided with exhaust fan and
ultra violet lamps.

30

6.

Capsules

100 sq. feet

Air Conditioner, De-humidifier, hygrometer,

thermometer, Capsule filling machine and
balance.

7.

Ointment/Marham
Pasai

100sq. feet

Tube filling machine, Crimping Machine,

Ointment Mixer, End Runner/ Mill (Where
required), S.S. Storage Container S.S.Patila.

8.

Pak/Avaleh/Khand/
Modak/Lakayam

100 sq. feet

Bhatti section fitted with exhaust fan and

should be fly proof, Iron Kadahi/S.S. Patila
and S.S. Storage container.

9.

Panak, Syrup / Pravahi

Kwath Manapaku

150 sq, feet

Tincture press, exhaust fan fitted and

fly proof, Bhatti section, Bottle washing
machine, filter press / Gravity filter, liquid
filling machine, P.P. Capping Machine.

10.

Asava / Arishta

200 sq. ft

Same as mentioned above. Fermentation

tanks, containers and distillation plant where
necessary, Filter Press.

11.

Sura

100 sq. ft

Same as mentioned above plusDistillation

plant and Transfer pump.

12.

Ark Tinir

100 sq. ft

Maceration tank, Distillation plant, Liquid

filling tank with tap / Gravity filter/Filter
press, Visual inspection box.

13.

Tail/Ghrit Ney

100 sq. ft

Bhatti, Kadahi/S.S. Patila, S.S.Storage

containers, Filtration equipment, filling tank
with tap/Liquid filling machine.

14.

Aschyotan / Netra
Malham Panir/Karn
Bindu/Nasa- bindu

100 sq. ft

Hot air oven electrically heated with

thermostatic control, kettle gas or electrically
heated with suitable mixing arrangements,
collation mill, or ointment mill, tube filling

15.

Each manufacturing
unit will have a separate
area for Bhatti, furnace
boilers, puta, etc.
This will have proper
ventilation, removal of
smoke, prevention of
flies, insets, dust etc. The
furnace section could
have tin roof.

200 sq. ft

31

B.

List of machinery, equipment and minimum manufacturing premises required for

the manufacture of various categories of unani system of medicines

One machine indicated for one category of medicine could be used for the manufacturing of other
category of medicine also. Similarly some of the manufacturing areas like powdering, furnace,
packing of liquids could also be shared for these items.

S. No.

Category of Medicine

Minimum manufacturing
space required

Machinery/equipment recommended

1200 square feet covered

area with separate
cabins, partitions for each
activity. If Ayurveda /
Siddha Medicines are also
manufactured in same
premises an additional area
of 400 square feet will be
required.
1.

Itrifal Tirya/majoon/
Laooq/Jawarish
Khamiras

100 sq. feet

Grinder/ Pulveriser, Sieves, powder mixer

(if required), S.S. Patilas, Bhatti and other
accessories, plant mixer for Khamiras.

2.

Arq.

100 sq. feet

Distillation Plant (garembic), S.S. storage

tank, Boiling Vessel, Gravity filter, Bottle
filling machine, Bottle washing machine,
Bottle drier.

3.

Habb (Pills) and tablets.

100 sq. feet

Ball Mill, Mass Mixer/Powder mixer,

Granulator drier, tablet compressing
machine, pill/vati cutting machine, stainless
steel trays/ container for storage and sugar
coating, polishing

4.

Sufoof (Powder)

200 sq. feet

Grinder / pulveriser, Sieves, Trays, Scoops,

Powder mixer (where required).

5.

Raughan (oils) (Crushing

and boiling)

100 sq. feet

Oil Expeller, S.S. Patilas, Oil filter bottle,

Filling machine, Bottle drier, Bhatti.

6.

Shiyaf, Surma, Kajal

100 sq. feet

End runner, mixing S.S. Vessel.

7.

Marham, Zimad
(Ointment)

100 sq. feet

Kharal, Bhatti, End runner, Grinder,

Pulveriser, Triple Roller Mill (if required).

8.

Qurs (Tab.)

100 sq. feet

Grinder/Pulveriser, Sieves, Powder mixer

(where needed), Granulator, Drier, Tablet
Compressing Machine, Die punches Trays,
O.T. Apparatus, Balance with weights, Scoops,
Sugar Coating Pan, polishing pan, Heater.

32

9.

Kushta

100 sq. feet

Bhatti, Kharal, Sil Batta, Earthen pots.

10.

Murabba

100 sq. feet

Aluminium Vessels 50-100 kgs. Capacity,

Gendna, Bhatti.

11.

Capsule

100 sq. feet

Pulveriser, Powder mixer (where needed),

capsule filling machine, Air conditioner,
De-humidifier, Balance with weights, storage
containers, glass.

12.

Sharbat and

100 sq. feet

Tinctum Press, exhaust fan fitted, Bhatti

section, Bottle washing machine, Filter
Press Gravity filter, Liquid filling tank with
tap/liquid filling machine, hot air oven
electrically heated with thermostatic control,
kettle.
Hot air oven electrically heated with
thermostatic control, kettle.

Joshanda

13.

Qutoor-e- Chashm and

Marham (Eye drops, eye
ointment)

100 sq. feet

14.

Each manufacturing
unit will have a separate
area for Bhatti, furnace
boilers, puta, etc.
This will have proper
ventilation, removal of
smoke, prevention of
flies, insets, dust etc.

200 sq. ft

C.

List of equipment recommended for in-house quality control section

(Alternatively, unit can get testing done from the Government approved laboratory).
(A)

CHEMISTRY SECTION

(B)

PHARMACOGNOSY SECTION

1.

Alcohol Determination Apparatus (complete set)

1.

Microscope Binoculor.

2.

Volatile Oil Determination Apparatus.

2.

Dissecting Microscope.

3.

Boiling Point Determination Apparatus.

3.

Microtome.

4.

Melting Point Determination Apparatus.

4.

Physical Balance.

5.

Refractometer.

5.

Aluminium Slide Trays.

6.

Polarimeter.

6.

Stage Micrometer.

7.

Viscometer.

7.

Camera Lucida (Prism and Mirror Type).

33

8.

Tablet Disintegration Apparatus.

9.

Moisture Meter.

10.

Muffle Furnace.

11.

Electronic Balance.

12.

Magnetic Stirrer.

13.

Hot Air Oven.

14.

Refrigerator.

15.

Glass/Steel Distillation Apparatus.

16.

LPG Gas Cylinders with Burners.

17.

Water Bath (Temperature controlled.)

18.

Heating Mantles/ Hot Plates.

19.

TLC Apparatus with all accessories (Manual)

20.

Paper Chromatography apparatus with

accessories.

21.

Sieve size 10 to120 with Sieve shaker.

22.

Centrifuge Machine.

23.

Dehumidifier.

24.

pH Meter.

25.

Limit Test Apparatus.

8.

Chemicals, Glassware etc.

D.

Supplementary guidelines for manufacturing of rasaushadhies or rasamaraunthukul and

kushtajat (herb-mineral-metallic compound) of ayurveda, siddha and unani medicines.

These guidelines are intended to complement those provide above and should be read in
conjunction with the parent guidelines. The supplementary guidelines are to provide general
and minimum technical requirements for quality assurance and control in manufacturing
rasaushadhies or rasamaraunthukul and kushtajat (Herb-mineral-metallic formulations).
These supplementary guidelines deal with Bhasmas, satwa(of Metals and Minerals origin)
Druti parpam, karpu and kushta etc. used in Ayurveda, Siddha and Unani Medicines.

The supplementary GMP guidelines for Rasaushadhies or Rasamaraunthukul and

Kushtajat are needed to establish the authenticity of raw drug minerals and metals, in

34

process validation quality control parameters to ensure that these formulations are
processed and prepared in accordance with classical texts and for which safety measures
are complied. Only those manufacturing units which have Good Manufacturing Practices
for ASU Drugs and supplementary certificate for Rasaushadhies or Rasamaraunthukul and
Kushtajat formulations shall be allowed to manufacture the same. Supplementary Good
Manufacturing Practices certificate for Rasaushadhies shall be issued by the State Licensing
Authority only after thorough inspection by an expert team including Rasashastra experts
nominated by the Department of AYUSH.

2.

Manufacturing Process Areas

For the Manufacturing of Bhasma and Kupipakawa and Rasaaushadhi preparations made
from metals and minerals the following specific areas shall be provided, which should
be completely segregated from the production areas used for preparations of plants and
animals by product based formulations to avoid cross contamination. The following
exclusive areas are required for Rasaushadhies or Rasamaraunthukul and Kushtajat.

2.2 (a) Bhatti or Heating Devise Section for Bhasma and Rasaaushadhi:- 100 sq. feet for heating,
burning, putta and any heat related work with proper ventilation, exhaust and chimney.
This could be tin shed also.
(b)

Grinding, Drying and Processing Section for Bhasma and Rasaaushadhi:- 10sq. feet (Manual
or mechanical, oven etc.). Drying may be done in a space which is covered by glass or other
transparent material to allow entry of sunrays on the material to keep for the purpose. If
drying is being in oven the temperature of the same may be selected specific temperature.

(c)

Rasaushadhis Related Store:- 100 sq. ft.

The size and Dimensions of each Bhatti section would be so designed ti suit the batch size
or quantity of materials to be processed, keeping in mind the processed, keeping in mind
the processing is done as per the conditions of Drugs and Cosmetics Act mentioned unde
Schedule I official books.

In additions to the fuel prescribed in the schedule books namely coal, fire woods, cow
dung cakes etc., use of other heating devices e.g. electrical heating, oil or gas fired furnace
and other may be employed so as to provide the required temperature as per the nature
of material and object of heating. Depending on the formulation being manufactured,
manufacturers may adopt aerobic or anaerobic process. Properly baked and clean earthen
pots of other crucibles and glass containers or appropriate design shall be used.
35

The manufacturing areas should be designed with special attention to process the products
that generate toxic fumes like SO2, arsenic and mercury vapour, etc. When heating and
boiling is necessary, suitable ventilation and air exhaust flow mechanism should be
provided to prevent accumulation of unintended fumes and vapours. Such areas may
be provided with properly designed chimneys or ducts fitted with exhaust systems and
suitable scrubbing system to remove fumes and smokes, so that safety of personnel and
environment is taken care of.

Since processing of Rasaaushadhi may introduce heavy metal contamination and cross
contamination etc., therefore, cleaning of equipment is particularly important after every
process by using appropriate cleaning agent which should not react with material of
equipment and must be free unwanted properties e.g. corrosiveness.

2.3

Records shall be maintained specially for temperatures attained during the entire process
of Bhasmikaran, while employing different kinds of classical puta, furnace using oil, gas
or electricity. Appropriate temperature measuring instrument should be employed such as
pyrometer and, pyrograph for manual reading or recording by heat sensors, connected to
computer, as the case may be.

In order to handle large quantities, appropriate technology like use of hand operated
extruders for making chakrikas or pellets may be adopted. However, such equipment
made of aluminium or its alloys should not be used.

Access to manufacturing areas shall be restricted to minimum number of authorised

personal only.

3.

Quality Control
A. In Process Quality Control

The registers as indicated below should exclusively be maintained for ready reference:(a) Shodhan Register with following details:
(1) Sl. No.
(2) Batch no. and Size
(3) Date, time and duration
(4) Name of the Raw-material with Quality reference and quantity
36

(5) Quantity of Shodhana Dravya

(6) Book reference followed
(7) Methodology
(b) Bhavana and Putta Register with following details:
(1) Sl. No.
(2) Batch no. and Size
(3) Date, time and duration
(4) Name of the material with Quantity of starting materials
(5) Quantity of nirvapya Dravya
(6) Quantity of Bhavana Dravya
(7) Date and Time of Starting and completion of Bhavana or Mardana and duration
(8) Type and Number of Puttas
(9) Time and Date of completion Puttas
(10) Colour and texture of the products or standards
(11) In process tests followed (Bhasma Pariksha and any other tests)
(12) In case heating at a particular temperature is required, record of attainment of that
temperature.
(c) Grinding Records Register: (Finished Products/Intermediate Procedure)
(1) Sl. No.
(2) Batch no. and Size
(3) Date, time and duration
(4) Name of the material with Quantity
(5) Name of the equipment (SS/granite)
(6) Duration of grinding
(7) Repeat the grinding if required (number of repetition )

37

(d) Packing details:

(1) Name of Rasaushadhi
(2) Type of Dosage Form (e.g. Powder, pill tablet etc.)
(3) Weight of Rasaushadhis in each unit.

B. Product Quality Control

The specifications for finished Rasaushadhi are primarily intended to define the quality
rather than to establish full characterization, and should focus on those characteristics
found to be useful in ensuring the quality. Consistent quality for Rasaushadhi can only be
assured if the starting material-metals and minerals are used of pharmacopoeial standards.
In some cases more detailed information may be needed on aspects of their process. The
manufacture will ensure in-house standards for the uniform quality of products.

Quality testing will be carried out as per official Pharmacopoeia or Schedule books for texts
namely, colour, taste, varitaratwa, Rekhapurnatwa, Laghutva, Nirudhumatwa, Dntagree
kachakacha, Niruttha, Apunarbhava and Nischandratwa.

The Particle size of products should be tested adopting microscopic fitted with micrometre
of particle size analyser or any appropriate other techniques. Required physio-chemical
characterization of the product should be undertaken by appropriate analytical equipment.
The Standard Manufacturing Process of the product should be evolved/follow up. The
disintegration time of pills-vati and tablets should also be recorded.

4.

Product recalls
Literature inserted inside the products package should indicate the name, address of
the manufacturing unit or email or telephone number for reporting of any adverse drug
reaction by physicians or patients. On receipt of such Adverse Drug Reaction report, it will
be the responsibility of the manufacturer to ensure the recall the product from the market.
Standard operating procedures (SOP) should be included for storage of recalled
Rasaushadhies in a secure segregated area, complying with the requirements specified for
storage, till their final disposal.

38

5.

Medical Examination of the employees

Employees engaged in manufacturing should be medically examined periodically at least
once a year for any adverse effect of the drug during manufacturing process fir which
necessary investigations may be carried out for ensuring that there is no effect of material
on the vital organs of the employees. Annual examination reports of the employees shall
be made available to statuary inspectors during Good Manufacturing Practices inspections

6.

Self- Inspection
The release of Rasaushadhis should be under the control of a person who has been trained
in the specific features of the processing and quality assurance of Rasaushadhis Personnel
dealing with the production and quality assurance of Rasaushadhis manufacturing section
should have an adequate training in the specific subject of Rasaushadhis manufacturing.
He will be at least a degree holder in Ayurveda/Siddha/ Unani medicine or B. Pharma
degree holder in Ayurveda/Siddha/ Unani medicine.

7.

Dosage form of Rasaushadhis

The Rasaushadhis may be made into an acceptable dosage forms such as, churna, vati, guti,
tablet, capsule etc. after adding suitable permissible fillers or binding agents as permissible
under the Ayurvedic Pharmacopoeia of India or Indian Pharmacopoeia as updated from
time to time. In such cases the label must indicate the Ayurveda/Siddha/ Unani medicine
in one Tablet or Pill or Capsule in addition to the filters. The crystalline product may
be grinded before packing in the individual dispensing size. All the Rasaushadhies or
Rasamaraunthukul and Kushtajat shall be packed in a dosage form which is ready for
use for the consumer. Grinding and weighting of individual dose of potentially poisonous
products will not be permissible in patient consumer pack. This arrangement may reduce
the Adverse Drug Reaction of Rasaushadhies which takes place due to dose variation.
However for hospital bulk pack, it will not be applicable and label will not be applicable
and label will clearly indicate the Hospital Pack.

39

8.

Area Specification/requirement for an applicant companies only to have GMP

of Rasaushadhies or Rasamaraunthukul and Kushtajat (Herbo-mineralmetallic compounds) of Ayurveda, Siddha and Unani Medicines:

S.
No.

Category of Medicine/
Manufacturing area

Minimum
Manufacturing
space required
(1500 sq. ft.)

Machinery equipment recommended

Pisti/ Grinding area for Bhasma.

Phisti, Kushtajat.

100 sq. ft.

Kharal/mechanized/motorized Kharal, End

runner/Ball-Mill Sieves/Shifter

Powdering area for raw drugs

of plant origin giving in
Rasaushadhies (Herbo-metallic
formulations)

200 sq. ft.

Grinder/ Disintegrator/Pulverisar/Powder
mixer/ sieves/ Shifter

Pills/Vati/Gutika Matrica and

tablets/Habb making area.

100 sq. ft.

Ball Mill, Mass Mixer/Powder mixer, Granulator

drier, tablet compressing machine, pill/vati
cutting machine, stainless steel trays/container for
storage and storage and sugar coating, polishing
pan in case of sugar coated tablets, mechanized
chattoo ( for mixing of guggulu) where required.

Kupi pakva/Ksara/Parpati/
Lavana Bhasma Satva/Sindura
Karpu/Uppu Param/Qushta/
Jawhar

150sq. ft.

Bhatti, Karahi/stainless steel vessels/patila flask,

Multani Matti/ palster of Paris, Copper Rod,
Earthen container, Gaj Put Bhatti, muffle furnace
(electrically operated) End/ Edge Runner, Exhaust
Fan, Wooden, S.S. Sapatula.

Receiving and storing raw material

200 sq. ft.

Quality Control Section

150 sq. ft.

Quarantine/observation

50 sq. ft.

Finished goods store

150 sq. ft.

Rejected Good Store

50 sq. ft.

10

Bhatti-Putta Area

200 sq. ft.

11

Area for water and washing etc.

50 sq. ft.

12

Office

100 sq. ft.

Total

1500 sq. ft.

Note:- The above requirements of machinery, equipments, space are made subject to the modification
at the discretion of the Licensing Authority; if he is of the opinion that having regard to the
nature and extent of the manufacturing operations it is necessary to relax or alter them in the
circumstances in a particular case (he may do so after recording reasons in writing)
40

SCHEDULE-TA
(See Rule 157-A)
Form for record of utilization of raw material by Ayurveda or Siddha or Unani Licensed
manufacturing units during the financial year.
Identification particulars
Manufacturing License no.....

Issued By .....

State:

Pin Code:.............

Telephone:..

Fax:...........

Name:..
Address:.

Email:..
Quantity of Medicinal Plants/Extracts/Essential Oils/ Metals/ Animal By-Products/
minerals used During 1st April, to 31st March, of the preceding year (For Productions at the
identified facility)

41

Others

Leaf

Root

Whole plant

Total

Imported

Cultivators

Part Used

Forest
Collectors

Sources of Supply

Traders/
Manufacturers

Quantity Used/
per annum (in
kgs)

Herbs Used

Plants Botanical
name

(a)

Common names
as in AFI/API

1.

Format of various forms used by Inspectors and other Regulatory Officers.

FORM 1A
Memorandum to the pharmacopoeial laboratory for indian medicine (plim)
From .
(Full name, Designation and Postal Address of the sender)
Serial No
To,

The Director, Pharmacopoeial Laboratory for Indian Medicine,

I send herewith under the provisions of section 11(2)/ section 25(4) and section 33-H of the
Drugs and Cosmetics Act, 1940, sample(s) of a drug purporting to be .. for test or
analysis and request that a report of the result of the test or analysis may be supplied to this Court.

1. The distinguishing number on the packet is..

3. Particular of offence alleged..

3. Matter on which opinion is required..

4. A fee of Rs.. has been deposited in court.

Date

......... ..
Magistrate/ Authorised Signatory

42

FORM 2A
Certificate of test or analysis from the pharmacopoeial laboratory
for indian medicine or government analyst

Certified that the samples, bearing number.. purporting to be a sample of
.. received on with memorandum No. dated . From
.. has been tested / analysed and that the result of such test / analysis is as stated below.
2.

The conditions of the seals on the packet on receipt were as follows:-

*3.
In the opinion of the undersigned the sample is of standard quality as defined in the Drugs
and Cosmetics Act, 1940 or rules thereunder for the reasons given below.
OR
In the opinion of the undersigned the sample is not of standard quality as defined in the Drugs
and Cosmetics Act, 1940 or rules thereunder for the reasons given below.
Note: *Delete whichever is not applicable.
Date

(Signature of the Analyst Person in Charge of testing)

Place

Name & Designation and Seal

Name & Address of the Laboratory)

FORM 15

(To be seen in context of section 33EEC)

Order under section 22(1)(c) of the drugs and cosmetics act,

1940 requiring a person not to dispose of stock in his possession

Whereas, I have reason to believe that the stocks of drugs/cosmetics in your possession,
detailed below contravene the provisions of Section 18 of the Drugs and Cosmetics Act, 1940;
Now therefore, I hereby require you under clause (c) of sub-section (1) of section 22 of the said
Act, not to dispose of the said stock for a period of .. days from the date of this order.
Date

Date

Inspector
Details of stock of drugs/cosmetics.
Inspector

43

FORM 16
Receipt for stock of drugs or cosmetics for record, register, document
or material object seized under section 22(1) (c) or 22(1)(cc) of the
drugs and cosmetics act,1940

The stock of drugs or cosmetics or records, registers, documents or material objects detailed
below has/ have this day has seized by me under the provisions of clause (c) or clause(cc) of
sub- section (1) of Section 22 of the Drugs and Cosmetics act,1940(23 of 1940) from the premises
of.. Situated at..
Date

Inspector..

Details of drugs, cosmetics, records, registers, documents or material objects seized.

Date

Inspector

FORM 17
Intimation to person from whom sample is taken
To,
.

I have this day taken from the premise s of situated at . samples of the
drugs/ cosmetics specified below for the purpose of test or analysis.
Date

Inspector..
Details of sample taken

Date

Inspector.

44

FORM 17-A

Receipt for samples of drugs or cosmetics taken where fair price tendered
thereof under sub-section (1) of section 23 of the drugs and
cosmetics act, 1940 is refused
To,

Whereas I, this day of .. [20 ]..have taken, from the premises of
situated at. samples of drugs/ cosmetics as specified below,Details of samples ..

And whereas I had offered to pay you rupees .. as the fair price of the samples of
drugs /cosmetics taken:
And whereas, you have refused to accept the fair price tendered thereof;

Now, therefore, I give you this receipt as the fair price tendered for the samples of the
drugs/cosmetics taken by me.
Date

Inspector..

FORM 18-A
Memorandum to government analyst
Serial No.

From...

To,

The Government Analyst

The portion of sample/ container described below is sent herewith for test or analysis
under the provisions of Section 33-H of the Drugs and Cosmetics Act, 1940.
The portion of sample/ container has been marked by me with the following mark.

Details of portion of sample or container with name of ingredients from which it is claimed
to be made.
Date

Inspector..

45

FORM 24-D

Application for the grant / renewal of a license to manufacture

for sale of ayurvedic / siddha or unani drugs
1.

I/We of hereby apply for the grant /Renewal of a license to manufacture

Ayurvedic (including Siddha) or Unani drugs on the premises situated at .

2.

Name of the drugs to be manufactured (with details).

3.

Names, qualification and experience of technical staff employed for manufacture and testing
of Ayurvedic (including Siddha ) or Unani drugs .

4.

A fee of rupees. has been credited to the Government under the head of
account.. and the relevant Treasury Challan is enclosed herewith

Date.
Signature .
(Applicant)
Note: The application should be accompanied by a plan of the premises

FORM 24-E
Application for grant or renewal of a loan license to manufacture
for sale /ayurvedic (including siddha) or unani drugs
1.

I/We* of !...........hereby apply for the grant /Renewal of a loan license to

manufacture Ayurvedic (including Siddha) or Unani drugs on the premises situated at
. C/#.

2.

Name of drugs to be manufactured (with details).

3.

Names, qualification and experience of technical staff actually connected with the manufacture
and testing of Ayurvedic (including Siddha ) or Unani drugs in the manufacturing premises.

4.

I/We enclose

46

a) A true copy of a letter from me / us to the manufacturing concern whose

manufacturing capacity is intended to be utilised by me/us.

b)

c) Specimen of labels, cartons of the drugs proposed to be manufactured

5.

A fee of Rs.. has been credited to the Government under the head of
account and the relevant Treasury Challan is enclosed herewith

A true copy of a letter from the manufacturing concern that they agree to lend the
services of their competent technical staff, equipment and premises for the
manufacture of each item required by me/us and that they shall maintain the
registers of raw materials and finished product separately in this behalf.

Date..

Signature (Applicant)

* Enter here the name of the proprietary, partners of Managing Director as the case may be.

! Enter here the name of the applicant firm and the address of the principal place of business.

# Enter here the name and address of the manufacturing concern where the manufacture
will be actually carried out and also the license number under which the latter operator.

FORM 25-D
License to manufacture for sale of ayurvedic(including siddha) or unani drugs
No. of license..
1.

..is /are hereby licensed to manufacture the following Ayurvedic (Including

Siddha) or Unani Drugs on the premises situated at under the direction and
supervision of the following technical staff-

a) Technical Staff(name)

b) Name of the drugs ( each item to be separately specify).

2.

The license shall be in force from .. to

3.

The license is subject to the conditions stated below and to such other conditions as may be
specified in the Rules for the being time in force under the Drugs and Cosmetic Act,1940

Date of issue.

Signature.
Designation
47

Condition of License
1.

The license and any certificate of renewal in force shall be kept on the approved premises and
shall be produced at the request of an Inspector , appointed under the Drugs and Cosmetic
Act,1940

2. Any change in the technical staff named in the license shall be reported forthwith to the
license authority.
3.

this license shall be deemed to extend to such additional items as the licensee may intimate
to the license authority from time to time, and as may be endorsed by the licensing authority.

4.

The licensee shall inform the licensing authority in writing in the event of any change in the
constitution of the firm operating under license. Where nay change in the constitution of the
firm takes place, the current license shall be deemed to be valid for a maximum period of
three months from the date on which the change takes place unless in the meantime a fresh
license has been taken from the licensing authority in the name of the firm with change
constitution.

FORM 25-E
Loan license to manufacture for sale of ayurvedic
(including siddha) or unani drugs
1.

Number of license..

2.

of..is hereby granted a loan license to manufacture for sale Ayurvedic

(Including Siddha) or Unani Drugs on the premises situated at C/o..
under the direction and supervision of the following expert technical staff-

a) Technical Staff (Name).

b) Name of the drugs (each item to be separately specify).

3.

The license shall be in force from .. to

4.

The license is subject to the conditions stated below and to such other conditions as may be
specified in the Rules for the being time in force under the Drugs and Cosmetic Act,1940

Date of issue.

Signature.
Designation
48

Condition of License
1.

The license and any certificate of renewal in force shall be kept on the approved premises and
shall be produced at the request of an Inspector , appointed under the Drugs and Cosmetic
Act,1940

2. Any change in the technical staff names in the license shall be reported forthwith to the
license authority.
3.

This license shall be deemed to extend to such additional items as the licensee may intimate
to the license authority from time to time, and as may be endorsed by the licensing authority.

4.

The licensee shall inform the licensing authority in writing in the event of any change in the
constitution of the firm operating under license. Where any change in the constitution of the
firm takes place, the current license shall be deemed to be valid for a maximum period of
three months from the date on which the change takes place unless in the meantime a fresh
license has been taken from the licensing authority in the name of the firm with change
constitution.

FORM 26-D
Certificate of renewal of license to manufacture for sale of
ayurveda/ siddha or unani drugs
1.

Certified that license No. granted on the .. to Shri/Messer for the

manufacture of Ayurvedic /Siddha or Unani Drugs at the premises situated at.has
been renewed from..to..

2.

Name of technical staff.

3.

Name of the drugs each item to be separately specified..

Date..

Signature
Designation

49

FORM 26-E
Certificate of renewal of loan license to manufacture for sale of
ayurveda/ siddha or unani drugs
1.

Certified that license No. . granted on the .. to..for the manufacture of

Ayurvedic /Siddha /Unani Drugs at the premises situated at.C/o has been renewed
from..to..

2.

Name of technical staff.

Date..

Signature
Designation

FORM 26E-I
Certificate of Good Manufacturing Practices (GMP) to
Manufacturer of Ayurveda, Siddha or Unani Drugs

Certified that manufacturing unit licensee, namely., situated at .. State.
License No. comply with requirements of Good Manufacturing Practices (GMP) of
Ayurveda-Siddha-Unani drugs as laid down in scheduled T of the Drugs and Cosmetic Rules,
1945.

This certificate is valid for a period of five years and the Good Manufacturing Practices(GMP)
is valid for various dosage forms or Rasaushadhis, as follows:Date..
Place.
Signature

Designation
*Licensing Authority/ Central License Approving Authority

Date of issue.
* Delete whichever is not applicable.
50

FORM 35
Form in which the inspection book shall be maintained
(A) The cover of the Inspection Book shall contain the following particulars, namely:

1 The name and address of the licensee

2. License number and the date up to which the license is valid.

(B) (i) The pages of the Inspection Book shall be serially numbered and duly stamped by the
Licensing Authority. The pages, other than the first and the last pages, shall have the
following particulars:Name and designation of the Inspector who inspects the premises of the licensee.
Date of Inspection
Observations of the Inspector

Signature of the Inspector

(ii) The first and last pages of the Inspection Book shall be endorsed by the Licensing Authority
with the following words, namely:

Inspection Book maintained by M/s . situated at for license number

. in Form under Drugs and Cosmetics Rules, 1945.

Seal and Signature of the Licensing Authority

Notes:

(1) Printed copy of the Inspection Book may be obtained by the licensee from the Licensing
Authority on payment.

(2) The Inspection Book shall be maintained at the premises of the licensee.

(3) The observations made by the Drugs Inspector shall be in triplicate. The original copy
shall be retained in the Inspection Book to be maintained in the premises of the licensee.
The duplicate copy shall be sent to the Licensing Authority. The triplicate copy shall be
taken as record by the Inspector.

51

FORM 47
Application for grant or renewal of approval for carrying out tests on ayurvedic, siddha and
unani, drugs or raw materials used in the manufacture thereof on behalf of licensees for
manufacture for sale of ayurvedic , siddha and unani drugs.
1)

*I / We . of. hereby apply for the grant / renewal of approval for

carrying out tests of identity, purity, quality and strength on the following categories of
Ayurvedic, Siddha and Unani drugs or raw materials used in the manufacture thereof on
behalf of licensee for manufacture for sale of Ayurvedic, Siddha and Unani drugs.

2)

* Categories of Ayurvedic, Siddha and Unani drugs other than those specified in the first
Schedule to this Act for which testing will be carried out:

3)
Ayurveda and Siddha

Unani

1. Asava and Arista

1 Nabeez Khal (Sirka)

2. Arka-Tinir

2 Majoon and its sub-categories :- Itrifal, Jawarish,

Khammera, Laooq halwa

Avaleha and paka-llakam

3. Sufoof, Zuroor, Sunoon

Kvatha Curna-Kutinir Curanam

4. Namak, khar

Guggulu

5. Raughan

Ghrita-Ney

6 Zimad

Churna-Curanam

7 Habb (Pill)

Taila-Tailam

8 Shiyaf

Dravaka-Tiravakam

9 Qutoor (drops)

Lavana-Uppu

10 Kohal ( Surama), Kajal

Kshara-Saram

11 Satt, Usara

Lepa-Pacai

12 Kushta

Vati, Gutika-Kulika

13 Joshanda ( single drugs)

Vartti

14 Sharbat, sikanjabeen

Netrabindu ( Aschyotan)

15 Sayyal, Arq (Distillates )

Ajana-Kanmai

16 Qurs ( Tablet)

Sattva-Sattu

17 Marham, Qairoota

Kupipakva Rasayan-Kuppi Centuram

18 Humool, Furzaja

Parpati

19 Bakhoor

Pishti

20 Nabati advia

Bhasma-Parpam

21 Maadni advia

Mandura-Atai-Kutinir

22 Ajsad Advia

52

Rasayoga-Centuram

23 Haiwani Advia

Lauha

24 Jauhar

Ghana Sattva

25 Natool

Kvath Pravahi-kutinir

26 Nashooq, Naswar

Panak (Syrup)- Manappaku

27 Shamoom

Tablet- Mattirai

28 Saoot( Nasai drops)

Capsule

29 Mazoogh

Ointment-Kalimapu

30 Tila

Phalavarti

31 Lashooq

Dhoomravarti/ Doopan

32 Gulqand

Kshar sutra/ Kshar Varti

33 Fateela

Single drugs:
Plant based, Mineral based, Metal based
Animal based, Synthetic
Any other Ayurvedic , Siddha and Unani
formulation

34 Ghaza, Ubtan, Sabhgh

Pushp (Phool)

35 Capsule

Nasya

36 Huqna

Swarsasa ( Fresh Juice)

37 Naurah

Karna Bindu ( Ear Drop)

38 Latookh

Any other dosage form of Patent and

Proprietary and Ayurvedic, Siddha and Unani
Drug.

39 Vajoor ( Throat pain)

40 Mazmazah ( Mouth washer)

4.

Names, qualifications and experience of experts employed for testing and the person in
charge of testing.

5.

List of testing equipment provided.

6.

*I /We enclose a plan of the testing premises showing the location and area of the different
sections thereof.

7.

An inspection fee of rupees.. has been credited to Government under the head of
Account.

Date
*

Delete whichever is not applicable

Inspector..

Full address of the applicant

53

FORM 48
Approval for carrying out tests or analysis on Ayurvedic, Siddha and Unani drugs or raw
materials used in the manufacture thereof on behalf of licensee s for manufacture for
sale of Ayurvedic , Siddha and Unani drugs.
Number of approval and date of issue
1.

Approval is hereby granted to.. .. to carrying out tests for identity , purity, quality and
strength on the following categories of Ayurvedic, Siddha and Unani drugs and the raw
materials used in the manufacture thereof on the premises situated.

Categories of Ayurvedic, Siddha and Unani drugs.

2.

Name of the experts employed for testing and the person-in charge of testing (experts)
and.. (Person in charge).

3.

The approval shall be in force from . To..

4.

The approval is subject to the condition s stated below and such other conditions as may be
specified in the rules for the times being in force under the Act.
Signature .
Designation.

Date.

Seal of State Licensing Authority

Place.

CONDITIONS OF APPROVAL
1.

This approval and any certificated of renewal in form 49 shall be displayed in the approved
premises and shall be produced at the request of the Inspectors appointed under the Act.

2.

If the applicant wishes to undertake during the currency of the approval the testing of the
any category of Ayurvedic, Siddha and Unani drugs it should apply to approving authority
for necessary endorsement as provided in Rule160-B. This approval will be deemed to extend
to this items so endorsed.

3.

Any change in the experts or in the person in charge of the testing shall be forthwith reported
to the approving authority.
54

4.

The applicant shall inform the approving authority b in writing in the event of any change
of the constitution of the laboratory operating under this Form. Where any change in the
constitution of the Laboratory take place, the current approval shall be deemed to be valid
for a maximum period of three months from the date on which the change takes place unless
in the meantime, a fresh approval has been taken from the approving authority in the name
of the laboratory with the changed constitutions.

FORM 49
Certificate of renewal for carrying out tests or analysis on Ayurvedic, Siddha and Unani
drugs or raw materials used in the manufacture thereof on behalf of licensees for
manufacture for sale of Ayurvedic , Siddha and Unani drugs.
1.

Certified that approval number ..granted on the .day of 2001 for carrying out tests
of identity, purity , quality and strength on the following categories of Ayurvedic, Siddha
and Unani drugs and the raw materials used in manufacture thereof at the premises situated
at..has been renewed from to.(Date).

Categories of Ayurvedic, Siddha and Unani drugs.

..

2.

Name of the experts and the person in-charge of testing.. (Experts) and (Personin-charge).

Date.
Place.

Signature.
Designation.
Seal of State Licensing Authority

55

Chapter III
Stepwise points for conducting GMP inspection
CHECKLIST OF GMP FOR DRUG INSPECTORS
CHECKLIST OF GMP INSPECTIONFOR DRUG INSPECTORS
S.
No

1.

GMP
Clause

Areas/Activities to be Audited

Observations
Document
Review

GENERAL
Name and address of Unit
MFG.Lic No.
Telephone
Fax:
Email:
Names and designation of the inspection team:

2.

PERSONAL
Name of In charge
a) production
b) quality control
Number of Production Supervisors/Asstt. Mfg./Chemist
Number of Analysts
Have all personal received GMP Training?
Is Training Documented?
What is the periodicity of the training?

3.

FACTORY PREMISES
Does manufacturing unit have adequate space for
Receiving and storing raw material.
Manufacturing process areas.
Quality control section.
Finished goods store.
Office
Rejected goods/drugs store.
56

Remark

4.

1.1 (A)

LOCATION AND SURROUNDINGS

Is the establishment located away from environmentally
polluted areas?
Is the establishment located away from areas adjacent to
open sewerage, drain/public lavatory or any factory which
produces excessive, disagreeable odour.
Are sewage, trash and other effluent disposal provided?

5.

1.1 (B)

BUILDINGS
Do the internal design and layout of establishment permit
good hygiene practices including protection from crosscontamination?
Are surfaces of walls, partitions and floors made of
impervious materials and capable of being kept clean?
Do walls and partitions have smooth surface?
Are floors constructed to allow adequate cleaning and
drainage?
Are doors, windows, ceiling and overhead fixtures
constructed and finished to minimize buildup of dirt,
condensation and shedding of particles and easy to clean?
Are working surfaces that come into direct contact with
drugs of sound condition, durable and easy to clean,
maintain and disinfect?
Any open drain blocked sewer or public lavatory nearby?
Are any products other than drugs manufactured in the
same building?
Is there adequate space for equipment, material and
movement of personal and materials?
Is there any programme/system to check of birds, rodents
and insects?
Are lightening and ventilation adequate?
Are facilities for changing street clothes, footwear, washing
and toilets adequately and satisfactorily maintained?
Is the space for drying of raw materials satisfactory?

57

6.

1.1 (C)

WATER SUPPLY
Is there adequate supply of potable water?
Does the potable water meet the specifications published
API specifications?
Is only potable water Used in ASU medicines?

7.

1.1 (D)

DISPOSAL OF WASTE
Are drainage and water disposal systems designed,
constructed and maintained in such a way as to avoid
contamination of ASU products?
Are the waste water and residues disposed of after suitable
treatment as per guidelines of pollution control authorities?
Are the arrangements for the following adequate?
Disposal of solid/semi solid waste
Disposal of sewage
Disposal of Liquid laboratory waste?
Disposal of Management of gaseous pollutants?
Is efficient treatment plant in existence / if yes, give
comment on it?
Are fume hoods of adequate design in existence and used
wherever necessary?

8.

1.1(E)

CLEANING OF CONTAINERS
Is there proper arrangement for washing, cleaning and
drying of containers?
Is this area separated from manufacturing area?

9.

1.1(F)

STORES
Is there independent adequate space for storage of different
types of materials such as raw material, packaging material
and finished products?
Are ASU medicine storage facilities designed and
constructed to Permit adequate maintenance and cleaning?
Avoid pest ace and harbourage?
Enable drugs to be effectively protected from
contamination?
Provided the necessary environment to prevent spoilage?

58

Are storage facilities deigned, constructed and maintained

to ensure that malicious or accidental contamination of ASU
medicines with harmful materials is prevented?
10.

1.1(F)(A)

RAW MATERIALS STORES

Are raw materials or ingredients checked for parasites,
undesirable microorganisms, pesticide or decomposed or
extraneous substances
Are raw materials or ingredients inspected and tested
before processing?
Are raw materials or ingredients subjected to effective stock
rotation?
Is the area adequate?
Are the ventilation and lighting of stores adequate?
Is the Raw Material store segregated for different types of
Raw Material?
Raw materials of metallic origin
Raw materials of mineral origin
Raw materials of animal source
Fresh herbs
Dry herbs or plant parts
Excipients etc.
Volatile oils/perfumes and flavours
Plant extracts and exudates/resins
Others
Is special area with special condition provided for special
Raw Materials?
Are there labels for material of different status i.e.
quarantine, tested and releases for use and rejected?
Are these labels of different colours?
Are labels on containers of RM to be used in manufacture
checked with regard to identity, quantity and QA approval?
If not give details/

59

Is there the following information on the labels?

Name of material
Batch number
Analysis number
Date of release/rejection?
Date of testing?
Date of expiry?
Is the sampling performed by quality control personal?
Are there sampling procedures?
Are the containers provided for storage of raw material
suitable to preserve the quality?
Is exterior storage available for :
Solvent storage area?
Inflammable material storage area?
Whether safety measures provided have been assessed by
regulatory agency if any?
Is SOPs available for handling of these materials?
Are SOPs for cleaning of containers and closures available
before packing of products?
Is the weighing area segregated?
Are lighting and ventilation adequate?
Is the area clean?
Do the personal wear appropriate clothing?
Is there danger of cross contamination during weighing?
Are the scales and balance calibrated regularly and records
maintained?
Are the containers of the raw materials to be weighed,
cleaned before opening?
After weighing, are these containers sealed?
Are the raw materials for each batch, after weighing
properly identified and checked?
Are adequately clean and dried equipment used for
dispensing materials from the containers?
Is FIFO principle adopted?
60

11

1.1 (F)(B)

PACKING MATERIALS
Is the area adequate with reference to packing material?
Are the containers and closures adequately cleared and
checked?

12.

1.1 (F)(C)

FINISHED GOODS STORES

Is the area adequate with reference to materials stored?
Are lighting and ventilation adequate?
Are there inventory records to show:
Quantities
Batch number
Date of receipt
Have the distribution records been maintained?
Do distribution records provide sufficient information for
drug recall purpose?
Is there segregation area for retrieved good?
Are records available for the retrieved goods?
Is there any marked quarantine area?
Is there space for special storage conditions (environmental
condition), if required?

13.

1.1 (G)

WORKING SPACE
Is space adequate as per manufacturing operations?
Is machinery alongwith working manual orderly placed
with adequate space?
Are there adequate precautions to check cross
contamination?

14.

1.1 (H)

HEALTH ,CLOTHING, SANITATION AND HYGIENE

OF WORKERS
Are workers free from contagious disease?
Are workers properly uniformed?
Are there separate lavatories for men and women?

61

Is there provision for changing their cloth and to keep

personal belongings?
Are adequate facilities like wash-basin with running water
hand drier & clean towels, etc., available for personal
hygiene before entering into production area?
Are personnel instructed to observe personal hygiene?
Are hygiene instructions displayed in change rooms and
strategic locations?
Is the sanitation system monitored for effectiveness?
Is the sanitation system periodically verified by inspections?
Is microbiological sampling of environment and ASU drugs
contact surfaces carried out?
Is the sanitation system regularly reviewed and adapted to
reflect changed circumstances?
15

1.1(I)

MEDICAL SERVICES
Is medical file of each worker maintained separately?
Is recruitment of an employee preceded by medical
examinations?
What is the periodicity of subsequent medical
examinations?
Is an employee whose state of health is doubtful
immediately removed from work site until he is fully
recovered?

16.

1.1 (J)

MACHINERY AND EQUIPMENT

Is manually operated or semioperated or automatic
machines are used for Crushing, grinding, powdering,
boiling, mashing, burning, roasting, filtering, drying, filling,
labelling and packing ?
Are equipment and containers coming into contact with
ASU drugs designed such that they can be adequately
cleaned, disinfected and maintained?
Are equipment made of nontoxic materials?
Are equipment used to cook, heat, treat, cool, store
designed to achieve the required temperature as rapidly as
necessary?
Are equipments used to cook, heat, treat, cool, store
designed to monitor and control the required temperature?
62

Are containers for waste suitably identified?

Are containers for waste closable to prevent malicious or
accidental contamination of ASU Medicines?
Is the equipment adequate for intended use?
Is it constructed in such a way that lubricants, coolant, etc.
cannot contaminate the drug product?
Does the equipment permit cleaning and maintenance?
Does the equipment show its status i.e. clean, dirty, batch
contents?
Do all apparatus/equipment bear appropriate labels to
identify the product for which the equipment is used, its
batch no., date of manufacturing etc.
Are SOPS available for cleaning maintenance and sanitation
of major equipment?
Are log books maintained for cleaning maintenance and
sanitation of major equipment?
Are SOPs readily available to operators
If automatic electronic or mechanical equipment is used ,are
there:
Written programs for calibration/inspection
Checks to ensure that may changes are made only by
authorized persons/
Are suitable closures or lids available to protect the changes
in properties of material exposed to outside atmosphere?
17.

1.1(K)

BATCH MANUFACTURING RECORDS

Are appropriate records of processing, production and
distribution kept?

63

Are SOPs available for the following

Receipt of raw material and other components?
Quarantine and storage?
Quality control system and approval/rejection
Release of production
In process testing and control
Finished product?
Storage of finished product?
Distribution
Returned goods
Recalls and complaints
Cleaning and maintenance?
Quality control of water
For reworking of non-conforming batches in existence? If
yes, check)
Are there additional documents like log books, notebooks
or other similar records available to show execution of
various functions?
Are there records of receipts of materials and do these have
following information? (goods receipt Note-GRN)
Receiving GRN documents number?
Date of receipt?
Supplier?
Manufacturer?
Manufactures batch number?
Type and size of containers?
Number of containers and conditions?
Are specifications available for all materials?
Are they dated authorized?
Are test methods validated?
Are periodic reviews of specification carried out to ensure
compliance with new /revised National/international
pharmacopoeia?

64

Are these records of stock and issue of raw materials and do `

these have following information:
Opening balance?
Date of receipt?
Quantity received?
Name and batch number assigned by the manufacturer?
Invoice number,date name and address of supplier?
Analysis receipt no. and date?
Date of expiry ,if any?
Name and batch number of product for manufacture for
which issued?
Balance?
Signature of issuing person?
Are there master formulation records for each drug product
being produced?
Is there a separate master production documents for each
dosage form/batch size?
Are these master production records signed and dated by
competent person?
Is a batch production record prepared for every batch
produced?
Is it reproduction of the appropriate master production
documents or it has all critical information about the batch?
Are batch records retained for at least one year after expiry
date?
Has it been checked for accuracy, signed and dated by a
responsible person?

65

Are the records maintained by QC for all the tests carried

out?
Do these records include:
The name of the product
Number of the batch being manufactured?
Issue slip with lab ref. No
Job cards?
Graphs, chart, spectra, etc?
List of major equipment used?
In-process testing reports?
Calculations of yield?
Notes on deviations with signed authorization?
Signature of individuals of who performed the tests?
Material returns to store slip?
Lab report of final product?
Review of results for any raw material issued under
positive Recall?
Signature of the designated person responsible for the
review of records for accuracy and compliance with
established standards?
Are other associated records available?
Is documentation available readily for examination?
Are batch production records capable of giving complete
history of the batch right from the raw material stage to the
distribution of finished products?
18

1.1(L)

DISTRIBUTION RECORD
Are records of sale and distribution of each batch of ASU
drugs maintained?
Are records maintained at least up to 5 years of the
exhausting of stock?

19

1.1 (M)

RECORD OF MARKET COMPLAINTS

Are the firm maintain a record of complaint received from
market?
Does the firm have investigated the complaint and has
taken any corrective action?
66

Does the firm has intimated such complaint six monthly to

the Licensing Authority?
Does the firm maintain register of any ADR report
received?
Are written procedure available for receipt and control of
return products?
Are returned or salvaged drug products destroyed unless
QC determines their reprocessing?
Are records of the returned products maintained including
their disposition?
Is a safety manual available?
20.

1.1 (N)

QUALITY CONTROL
Is the QC area more than 150 sq ft?
Has Quality Control section minimum of:
a) One person with Degree qualification in Ayurveda/
Siddha/Unani;
b) One chemist with bachelor in Science or Pharmacy or
Pharmacy (Ayurveda) and;
c) One Botanist (Pharmacognosist) with bachelor in Science
(medical) or Pharmacy or Pharmacy (Ayurveda)?
Are master control procedures signed and stated by
authorised persons?
Do these control procedure include specifications, test
procedure or other control procedure for:
Raw materials
In process materials
Packaging and labelling materials?
Finished products?
Are the procedure in written form and readily available to
QC personnel for acceptance of reprocessed material?
Are the procedure in written form and readily available for
acceptance of reprocessed material?
Do these control procedure include specifications test
procured or other control procedure for :

67

Raw material
In process material
Packaging and labelling materials
Finished products?
Are samples collected by QC personal
Is there special room for microbiological and sterility
testing?
Is the environment of room controlled?
Are only materials, containers and appliance necessary for
the job in hand stored in the vicinity of the manufacturing
areas and are these properly labelled with name of the
product, batch no. date etc.?
Are all raw materials, containers, closures, label and printed
packaging material approved and released by QC for use in
manufacture of drugs products
Are in-process controls carried out by QC personnel?
Are semi-finished products tested for appropriate tests
when necessary?
Is bulk finished product tested for established specifications
before packing?
Is every finished product tested for established
specifications before release for sale?
Does the QC maintain records of all the tests carried out?
Does the QC review all production and control records
to ensure compliance with established written procedure
before a batch of the product is released for sale?
Reference standards:
Are reference standards (R.S) available?
Are these RS or working standards (WS)?
Are WS standardised against RS or CRS?
Are RS stored properly (at appropriate temperature under
dehumidified conditions)?
Are records of R.S and their standard maintained?

68

Are samples in sufficient quantity for testing twice retained

of starting materials and finished products for future
examination, in case of need?
Are quality control procedures validated?
Is written programs available for stability including the
following:
Sample storage condition
Room temperature?
Sample size and test intervals?
Reliable and specific test methods?
Testing in the same containers closure system in which it is
marketed?
Date and expiration date if any?
Established of in-house specification?
Does the firm provided the equipment as recommended in
Part II C ?
21

1.2

REQUIREMENT FOR STERILE PRODUCT

Manufacturing areas
Is there separate manufacturing area
Are their air locks for entry?
Is there dust free and ventilated for air supply
Precautions against contaminations and mix.
Are manufacturing operations being carried out in a
separate block of adequately isolated building
Is there appropriate pressure differential in the process area.
Is suitable exhaust system provided?
For asceptic manufacturing proper air supply (filtered
through HEPA) provided?

69

Chapter IV
Modalities for issuance of WHO GMP Site Certificate and
CoPP for Herbal Products.
Many importing countries ask for Certificate of Pharmaceuticals Product (CoPP)
during import of Herbal products.
1)

Those who want to take WHO-GMP certificate for herbal medicine have to submit application
to Drugs Controller General (India), giving following information for each product:

i) Name and address of manufacturing facility.

ii) Name of the contact person of product license holder.

iii) Name and dosage form of product.

iv) Name and amount of active ingredient(s) per unit dose (International Non-proprietary
Name(s) where such exist(s).

v) Formula (complete composition including all excipients; also particularly when no

product license exists or when the formulation differs from that of the licensed product)

vi) Product information for health professionals and for the public (patient information
leaflets) as approved in the exporting country.

2) A Site Master File has to be submitted as recommended in the WHO technical report series.
3) The Drugs Controller General (India), in consultation with Department of AYUSH will fix
the date of inspection.
4) Drugs Controller General (India) will constitute inspection team/ Committee comprising:

a) Expert from Department of AYUSH

b) Nominee of DCG(I)

c) State Drugs Controller/Licensing Authority

5) Inspection team/ Committee will make inspection as per the Check list and submit report to
DCG(I).
6) The recommendation of the Inspection team/committee, will be examined by DCG(I) and if
found suitable, DCG(I) will issue Certificate of herbal Pharmaceutical Products.

70